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BACKGROUND: 
  Chronic obstructive pulmonary disease (COPD) is a complex multicomponent 
disease which is associated with cognitive impairment due to neuronal damage mediated by  
hypoxia. Cognitive impairment affects the self-management, clinical management and 
pulmonary rehabilitation of COPD subjects. Progressive impairment of the auditory P300 
evoked potential with prolonged latency occurs with increasing severity of COPD. So routine 
screening of  COPD  patients for cognition is helpful in assessing the progression of  the 
disease.  
 AIM: 
            To assess the cognitive function  and to correlate it with arterial oxygen saturation in 
stable COPD patients  and  age matched controls.  
 OBJECTIVE:  
           To assess  cognitive functions in  stable COPD patients  and  age-matched  healthy 
controls using Cognitive evoked potential (CEP) study, Mini mental status examination 
(MMSE)  and Stroop test to correlate them with Arterial oxygen saturation ( SpO2) using 
Pulse oximetry and Arterial oxygen tension ( PaO2) by arterial blood gas analysis.  
MATERIALS  AND METHODS: 
  The study  population were 50 Stable COPD patients and 50 controls. They were 
subjected to MMSE,  Stroop test, and CEP  study  and SpO2 measured by Pulse oximetry. In 
addition, Arterial blood gas analysis was done for the patients to measure PaO2. The data 
were analyzed using  Mean, Standard deviation, Independent t-test, ANOVA and Tukey post 
hoc  test and pearson's correlation were used for analysis. The mean difference was 
significant when p < 0.05 level. 
RESULTS:  
 In  stable COPD patients, MMSE score  was significantly  lower, interference score 
was significantly increased in Stroop test and prolonged N100,P300 latency and reduced  P300 
amplitude in CEP study than in controls. SpO2  by pulse oximetry shows significant decrease 
in patients than in the controls. There is positive correlation between P300 amplitude and PaO2 
in the patients. 
CONCLUSION: 
  There is significant cognitive impairment in Stable COPD patients as evidenced by 
MMSE, Stroop test,  and CEP  study We recommend CEP study as a screening tool in 
Stable COPD patients to detect early cognitive impairment so that timely intervention 
can be planned  to improve  the quality of their life. 
Key words : Stable COPD patients, Cognitive evoked potential, P300,  MMSE, Stroop 
test, Cognition. 
 
INTRODUCTION 
The Objective of Global initiative for chronic Obstructive Lung Disease 
(GOLD) is," to increase awareness of COPD among health related officials and 
general community, to improve  the  diagnosis,  management  and  prevention  
of  COPD,  and  to  encourage  exploration in  COPD". 
COPD is a  major public health problem. It  is a group of chronic lung 
disorders, specifically encompassing Emphysema and Chronic Bronchitis  and  
about  600 million people  are affected globally and it is now  the fourth leading 
cause of death and it is the only cause of  mortality whose incidence continues 
to rise and will be the third cause  by 20201. In India, 53% of all deaths were  
estimated to be due to Non communicable diseases and 44% of DALY 
(disability adjusted life years) lost in 2005.Of these7% deaths and 3% DALYs 
lost were due to Chronic Respiratory diseases 2.There are 30 million COPD 
patients in India as estimated approximately3. In India burden of Chronic 
Bronchitis was estimated as 14.84 million. 
The reported prevalence is from 2 to 22% in men & from 1.2 to 19% in 
women.4 Tobacco use is the main cause of global wave of smoking-related 
illnesses resulting in 5.4 million deaths worldwide each year and it will increase 
to 6 million by 2015. 30% of the tobacco-related deaths will be caused by 
chronic respiratory diseases5. Cigarette smoking is the leading cause of COPD 
which causes 56 times more possibility of illness than the non-smokers6. 
Passive smoking, air pollution, and occupational chemical fumes or dust may 
act synergistically with active smoking to increase the risk of COPD7. 
COPD is a multicomponent  non communicable disease with  not only  
primary pulmonary involvement but co morbidities like cardiovascular disease, 
osteoporosis, anaemia  depression and cognitive impairment is one among them. 
The Airflow limitation in COPD  is not reversible and the disease is progressive 
but it is preventable and treatable8. It is a multisystem disorder with both 
physical effects and impaired psychological and cognitive functioning. In 
addition  to the involvement of motor nerve, encephalopathy and cognitive 
dysfunction have been noted in patients with chronic respiratory insufficiency. 
Kayakan et al (2001) observed that  cigarette smoking, limitation of airflow, and  
COPD in the last stage causes hypoxemia and hypercapnia  which involves the 
pontomedullary  portion of the brain9. Stable COPD patients are those who are  
on regular medical intervention for the past 4 weeks. 
Cognitive impairment is one of the extra pulmonary feature of COPD10 
Cognition is the higher intellectual function of the brain. The cognitive decline 
of the individual results in a great burden on the self, family and community.  
The incidence of cognitive dysfunction in COPD patients varies in different 
studies from 12% to 88%11. Domains of cognition are memory, learning ability 
both visual and verbal, attention or vigilance, concentration, abstract thinking, 
and problem solving. Neurocognitive defects such as  slowed information 
processing speed, poor learning, poor memory and attention deficit are well 
documented in COPD patients by various studies. The most affected cognitive 
domain is  memory and attention, though speed, coordination and learning 
abilities are also affected. Increasing age and low level of education are also 
associated with cognitive impairment. J. W. Dodd et al  in 2010 described a 
specific pattern of cognitive impairment in patients with COPD.12 Patients  find 
very difficult to breath,  and are much depressed, dysfunctional, disabled, 
desperate, and are very difficult to deal with. They are encouraged to become 
more knowledgeable about the disease, to actively involve in self management  
and  to become more independent in daily activities2. Cognitive dysfunction 
reduces the level of functioning13,14, and it is associated with poor compliance 
with both medication and oxygen therapy which  increases the risk of acute 
exacerbation. 
Cognitive impairment affects functional, social, emotional, affective, and 
communication skills. Also Impairment of Cognition  predicts mortality in 
hypoxemic COPD patients.15 A good cognitive status is essential for the 
individual to understand his real state and to abstain from smoking, which  
makes his life dejected by affecting his lung function. Level of cognitive 
functioning of these patients must be taken into consideration before self-care 
can be planned and it is modified toward the patient’s individual capability and 
needs. Number  of studies have been done in the past which says that patients 
with COPD have  poor quality of life and is again confirmed by Kaplan and 
Ries16,17.  
In most of the previous studies, they had used neuropsychological battery 
of tests to assess various domains of cognition. There are only few studies in the 
literature which have employed electrophysiological tests to quantify cognitive 
impairment in COPD. Also Pulmonary Rehabilitation which is an important 
aspect of treatment for COPD patients should  include initial evaluation  of  
patient's  cognition, psychological state, social support etc which is very 
important to improve the quality of life in COPD patients. Also cognitive 
training should be included in the treatment schedule of COPD patients 
especially in long term Pulmonary rehabilitation programs. 
The term arterial oxygen saturation the percentage of Hb molecules 
which are saturated with oxygen (SpO2) which is SaO2 measured by pulse 
oximetry.SpO2 is related to partial pressure of oxygen in a complex way in 
oxyhaemoglobin dissociation curve. Partial pressure of oxygen is the arterial 
oxygen tension and it is blood oxygen level   Hypoxemia produces varying 
responses in different tissues greatest need is to the brain and heart.  
 In the present study, in addition to the Mini Mental State 
Examination(MMSE) and Stroop test, Cognitive evoked potential study was 
done to assess cognitive function in the Stable COPD patients. MMSE is a brief, 
quick objective method of assessing global cognitive functioning. It is a reliable 
and validated method commonly used to assess cognitive status. The Stroop 
Colour Word Test is used to assess cognitive flexibility.18 The interference score 
in Stroop test gives the measure of inhibition of a habitual response (reading) 
which is part of the executive functioning. It measures focussed attention. CEP 
analysis is to investigate specific types of information processing by the brain. 
Cognitive evoked potentials are electric signals from the brain generated while 
performing various cognitive tasks. It is produced when the person attends to 
and discriminates between stimuli which differ from one another in some 
dimension such as modality, intensity, frequency or duration. Cognitive evoked 
potential study is recommended for detecting and quantifying early cognitive 
impairment which is not usually detected by other traditional methods of 
assessment of cognition.19 
  The present study was undertaken to assess the cognition in the Stable 
COPD patients using Mini Mental State Examination and Stroop test and 
Cognitive Evoked Potential study and compare it with that of normal 
individuals, and to correlate with Arterial partial pressure of oxygen.   
The possibility of using cognitive evoked potential as an investigatory 
tool to detect early cognitive impairment in Stable COPD patients was being 
explored in the present study along with neuropsychological tests. 
I hypothesise that stable COPD patients have cognitive dysfunction 
depending upon the severity of air flow obstruction due to chronic hypoxia.  
 
  
  
 Review of literature  
REVIEW OF LITERATURE 
Chronic obstructive pulmonary disease (COPD) is a multi component 
disease in which cognitive dysfunction is one of the components. Cognitive 
function is essential for daily activities like attention, concentration, memory, 
logical thinking, reasoning and execution of a motor act.  
In this section, the literature relevant to COPD and COGNITION in terms 
of the following side headings is being discussed. 
1. Historical Aspects 
2. COPD                                       
3. Pulmonary Function Tests 
4. Cognition 
5. Neuropsychological test – MMSE and Stroop test              
6. Neurophysiological test – Cognitive evoked potential study 
7. Pulse Oximetry and Arterial Blood Gas Analysis.            
 
 
HISTORICAL ASPECTS 
In the early days, the term lung was not mentioned in the body except 
for"pneuma" or vital spirits and air of universe. Respiratory system was studied 
after circulatory system and this was done by Robert Boyle (1627-1691), an 
Irish scholar. He proved that candle will stop burning when kept in an airless 
jar. Joseph Priestly discovered oxygen, dephlogisticated air. Antonie 
Lavoisier, (1743-1794) a French chemist, confirmed that oxygen is in inspired 
air and carbon dioxide is in expired air.24 
People regarded life as one and the same with breathing and life starts 
and finishes with breathing. The BIBLE says that God breathed the breath of 
life into the nostrils of ADAM and then took a rib from ADAM'S chest, to give 
life to Eve. In 5th and 6th B.C., Hippocrates said that the function of lung is to 
cool the heart. In 18th Century, the true role of breathing was established after 
the study of chemistry of gases.25 
The word Emphysema has its origin from the Greek meaning "to blow 
into" and was described by Bonet in 1676 and Morgagni in 1769. Ruysh in 
1721, described emphysema in humans with illustrations. 
Matthew Baillie in 1807, documented, illustrated and denoted the real 
destructive character of emphysema. 
In 1892, William Osler in his "Text book of Medicine"  described 
hypertrophic emphysema as," a well marked clinical affection, with 
enlargement of lungs due to distension of airways and atrophy of their walls, 
and clinically by imperfect aeration of blood and more or less dyspnoea."26 
J. Gough in 1952, described centrilobar emphysema. Gough & 
Wentworth developed paper section technique. 
McLean gave a comprehensive microscopic description of emphysema 
and demonstrated the relationship of destruction to inflammatory alterations of 
the bronchioles and vessels.  
Laennec, who invented stethoscope in 1819 first characterised  
emphysema  by making  clear-cut peculiarities of  interstitial emphysema and 
emphysema proper and correlated the enlarged airspaces to the clinical 
syndrome of emphysema. He documented that air trapping and increased 
collateral ventilation were features of emphysema and  the primary site of 
obstruction were the peripheral airways. Airspace enlarges as age increases, but 
it was distinguished from emphysema. He was the first to describe an 
association of emphysema with chronic bronchitis and described the pathology 
of bronchiectasis.27 
Galen(129-200 AD) did a volumetric experiment on human ventilation. 
In 1793, Menezies R determined the tidal volume using body plethysmograph. 
John Hutchinson, a surgeon pointed out that the volume of air exhaled after a 
full inflation is an indicator of longevity of life. The water-sealed volume-
displacement spirometer was invented by him in 1844 to measure the vital 
capacity i.e. the capacity to live. Spirometry is the most simple and useful 
method available to evaluate the pulmonary function. 
Early work on respiratory function was done in 1920s with blood gas 
measurements technique. In 1925, Meakins & Davies explained most 
derangements of function in terms of disorders of blood gases. Barcroft & 
Haldane clarified the basic gas transport.28The electrolyte theory of dissociation 
was proposed by Svante Arrhenius NP (1859-1927) for which he was awarded 
Nobel prize. The definition for acid was given by Johannes N Bronsted (1879-
1947). The relationship between pH, pKa, concentration of acid and conjugate 
base is expressed by the Henderson-Hasselbach equation given by Lawrence J 
Henderson (1878-1972) and KA Hasselbalch (1874-1962)29. 
The name P300 was given by Smith et al. It is a parietocentral positivity 
that occurs when a subject detects an informative task-relevant stimulus. It is 
obtained 300ms after a subject makes a simple sensory discrimination. P3 or P300 
is the third major positive peak in the late sensory evoked potential (Ritter et al., 
1968) and the late positive component (Sutton et al., 1965, 1967). Sutton et al 
described this late positive component and it is endogenous. Ritter and 
Vaughan in 1969 used the "oddball paradigm" wherein the subject detects 
occasional target  signals randomly interspersed among frequent standard 
stimuli. He also described parietocentral scalp distribution of the P300. Previous 
research on P300 has been done exclusively in humans. But localisation of the 
neural generators contributing to P300 will require depth recording and lesion 
experiments which were done in cats which gives anatomical and physiological 
information.   
Aristotle gave attention to the cognitive process more than twenty-three 
centuries ago. Aristotle focussed on cognitive areas pertaining to memory, 
perception, and mental imagery.  In the15th century, it meant thinking and 
awareness. Other scientists like Wilhelm Wundt, Herman Ebbinghaus, Mary 
Whiton Calkins, and William James, and some others offered their 
contributions to the study of cognition. 
CHRONIC  OBSTRUCTIVE PULMONARY DISEASE 
Natural History of COPD:  
 In the year 2009, the Framingham Offspring cohort study (prospective) 
was done from adolescent  to old age for 23years in both sexes. The 
following  observations were made: 
(1) the normal rate of decline in lung function in healthy non-smokers is 
less 
(2) the dreadful effect of smoking cigarettes on  the rate of lung function 
decline is similar in both sexes 
(3) the presence of respiratory symptoms identifies that smokers  are 
particularly susceptible to the development of airflow limitation.  
(4) the advantage of quitting smoking is more marked when it is done 
earlier.  
In the Rotterdam Study, that addresses the important issue of 
markedly high  incidence of COPD in the youngest women, which suggests a 
further shift toward  females in the sex distribution of COPD. D espite this 
potential change in incidence, mortality remains higher in males than females, 
even in well-matched BODE [body mass index, airway obstruction, dyspnea, 
and exercise capacity] patients. 
 Chronic obstructive pulmonary disease (COPD) is defined as a disease 
state characterized by airflow limitation that is not fully reversible accompanied 
by inflammatory responses to noxious particles or gases. COPD includes 
emphysema, chronic bronchitis, and small airways disease. COPD is present 
only if chronic airflow obstruction occurs. It excludes asthma, bronchiectasis, 
bronchiolitis, and cystic fibrosis. It causes maximal expiratory airflow limitation 
and it is the severity of the limitation that is abnormal in COPD. 
Risk factors include host and environmental factors. By 1964, the 
Advisory Committee to the Surgeon General of the United States had concluded 
that cigarette smoking was a major risk factor for mortality from chronic 
bronchitis and emphysema. Second less common risk factor is a hereditary 
deficiency of α1 antitrypsin.  
Lower socioeconomic status is associated with significantly increased 
risk for development COPD. Men often have a significantly increased risk for 
development COPD due to cigarette smoking and the habit of retaining the cigar 
in the mouth between puffs and extinguishing and relighting cigars. Other 
factors include air pollution, infection especially in childhood, climate, 
hereditary, socioeconomic status, atopy, nonspecific airway hyper 
responsiveness, diet and nutrition. Tobacco smoke is a complex mixture  of 
more than 100 volatile and particulate chemical substance. The enormous 
impact of smoking and COPD on mortality was first studied by Doll & Hill.34 
Individuals whose lung function is impaired for any reason are at 
increased risk for development of symptomatic COPD and this is called as 
Horse race effect34. 
In the early stages of the disease there are no clinical findings. By the 
time the disease is diagnosed the disease is far advanced. Subsequent 
longitudinal studies have shown accelerated decline in the volume of air 
exhaled within the first second of the forced expiratory manoeuvre (FEV1) in a 
dose-response relationship to the intensity of cigarette smoking, which is 
typically expressed as pack-years (average number of packs of cigarettes 
smoked per day multiplied by the total number of years of smoking). The 
traditionally higher rate of smoking among males is the likely explanation for 
the higher prevalence of COPD among males2 
 
 
 
 
 
 
FIGURE - 1 
TYPICAL PROGRESSION OF THE SYMPTOMS OF COPD. 
 
  
Pathophysiology:  
Most important abnormalities that occur in COPD are,  
a) Chronic obstruction  
b) Entrapment of air in the alveoli and marked destruction of alveolar 
walls   
c) Chronic infection  
d) Increased airway resistance and increased work of breathing 
e) Decreased diffusing capacity 
f) Extremely abnormal ventilation perfusion ratio 
 low Va /Q  Physiologic shunt  in some parts of lung lead to poor 
aeration of blood .                                             
 high Va/Q  Physiologic dead space in some parts lead to wasted 
ventilation. 
g) Increase in pulmonary vascular resistance 
Persistent reduction in forced expiratory flow rates is the most 
characteristic finding in COPD. Increases in the residual volume and the 
residual volume/total lung capacity ratio, non-uniform distribution of 
ventilation, and ventilation-perfusion mismatching also occur. Airflow 
limitation or airflow obstruction is determined by spirometry, which involves 
forced expiratory manoeuvres after the subject has inhaled to total lung 
capacity28. 
 Patients with airflow obstruction related to COPD have a persistently 
reduced ratio of FEV1/FVC. The reduced FEV1 in COPD does not respond to 
inhaled bronchodilators. Airflow during forced exhalation is the result of the 
balance between the elastic recoil of the lungs promoting flow and the 
resistance of the airways limiting flow. In normal lungs, as well as in lungs 
affected by COPD, maximal expiratory flow diminishes as the lungs empty 
because the lung parenchyma provides gradually less elastic recoil and because 
the cross-sectional area of the airways falls, raising the resistance to airflow.  
In COPD there is "air trapping" (increased residual volume and increased 
ratio of residual volume to total lung capacity) and progressive hyperinflation 
(increased total lung capacity) during the final stages of the disease. 
Hyperinflation of the thorax during tidal breathing conserves maximum 
expiratory airflow, because as lung volume increases elastic recoil pressure 
increases, and airways enlarge so that airway resistance decreases.  
 The PaO2 usually remains near normal until the FEV1 is decreased to 
~50% of predicted, and even much lower FEV1 values can be associated with a 
normal PaO2, at least at rest. 
 A rise of arterial level of carbon dioxide (PaCO2) does not occur until the 
FEV1 is <25% of predicted. Pulmonary hypertension severe enough to cause 
corpulmonale and right ventricular failure due to COPD typically occurs in 
individuals who have marked decrease in FEV1 (<25% of predicted) and 
chronic hypoxemia (PaO2<55 mmHg) 
Pathology: 
Changes in Large Airway: 
Cigarette smoking often results in mucous gland enlargement and goblet 
cell hyperplasia leading to cough and mucus production. There is bronchial wall 
inflammation and fibrosis. Patients have smooth-muscle hypertrophy and 
bronchial hyper reactivity leading to airflow limitation. Neutrophil influx has 
been associated with purulent sputum of upper respiratory tract infections. 
Independent of its proteolytic activity, neutrophil elastase is among the most 
potent secretagogues identified.  
Changes in Small Airways 
The major site of increased resistance in most individuals with COPD is 
in airways <2 mm diameter. Characteristic cellular changes include goblet cell 
metaplasia, with mucus-secreting cells which replaces surfactant-secreting Clara 
cells. There is mononuclear phagocytes infiltration and smooth-muscle 
hypertrophy. These cause luminal narrowing by fibrosis, excess mucus, edema, 
and cellular infiltration. Reduced surfactant may increase surface tension at the 
air-tissue interface, predisposing to airway narrowing or collapse. Respiratory 
bronchiolitis with mononuclear inflammatory cells collecting in distal airway 
tissues may cause proteolytic destruction of elastic fibers in the respiratory 
bronchioles and alveolar ducts where the fibers are concentrated as rings around 
alveolar entrances.32 
            Because small airway patency is maintained by the surrounding lung 
parenchyma that provides radial traction on bronchioles at points of attachment 
to alveolar septa, loss of bronchiolar attachments as a result of extracellular 
matrix destruction may cause airway distortion and narrowing in COPD. 
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 Changes in Lung Parenchyma 
Emphysema is defined pathologically by The National Heart, Lung, 
and Blood Institute as," an abnormal condition, permanent enlargement of 
distal airspaces, distal to the terminal bronchiole accompanied by destruction of 
their walls and without obvious fibrosis". 
Emphysema is characterized by destruction of gas-exchanging air spaces, 
i.e., the respiratory bronchioles, alveolar ducts, and alveoli leading to loss of 
lung elasticity. Their walls perforate and later obliterate that result in 
coalescence of small distinct air spaces into abnormal and much larger air 
spaces. Macrophages accumulate in respiratory bronchioles of essentially all 
young smokers. 
Emphysema is classified into distinct pathologic types, the most 
important being centriacinar and panacinar emphysema. 
Centriacinar emphysema, the type most frequently associated with 
cigarette smoking, is characterized by enlarged air spaces found (initially) in 
association with respiratory bronchioles.  It is most prominent in the upper lobes 
and superior segments of lower lobes and is often quite focal. It is most 
common in males. 
 Panacinar emphysema refers to abnormally large air spaces evenly 
distributed within and across acinar units. It is usually observed in patients with 
α1AT deficiency, which has a predilection for the lower lobes. 
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Pathogenesis: 
Airflow limitation, the major physiologic change in COPD can result 
from both small airway obstruction and emphysema. Fibrosis surrounding the 
small airways appears to be a significant contributor. Collagen accumulation 
around the airways in the face of increased collagenase activity remain an 
enigma. Proteinase can predispose to fibrosis, including proteolytic activation of 
transforming growth factor  (TGF).  
           The dominant concept of the pathogenesis of emphysema comprises of 
four interrelated events.  
(1) Chronic exposure to cigarette smoke may lead to inflammatory cell 
recruitment within the terminal air spaces of the lung. 
(2) These inflammatory cells release elastolytic proteinases that damage the 
extracellular matrix of the lung.  
 (3) Structural cell death results from oxidant stress and loss of matrix-cell 
attachment. 
(4) Ineffective repair of elastin and other extracellular matrix components 
result in air space enlargement that defines pulmonary emphysema. 
 Chronic Bronchitis  is defined  clinically by The British Medical 
Research Council as," presence of chronic productive cough on most of the 
days for three months, in each of two consecutive years in a patient in whom 
other causes of chronic cough has been excluded". Diagnosis is based on the 
history of excessive expectoration of mucus.  
 
 
 
 
Disease Process Anatomic Location of 
Lesion 
Cause of Reduced   
Airflow 
Chronic bronchitis Large and small (<2-
mm diameter) airways 
 
Narrowing of airways 
by fibrosis, secretions, 
edema 
Emphysema Lung parenchyma Loss of lung elastic 
recoil 
 
THE ELASTASE:ANTIELASTASE HYPOTHESIS 
 Patients with genetic deficiency in α1AT, the inhibitor of the serine 
proteinase neutrophil elastase, were at increased risk of emphysema, and 
instillation of elastases, including neutrophil elastase to experimental animals 
resulted in emphysema. The elastase : antielastase hypothesis remains a main 
mechanism for the development of emphysema. However, a complex network 
of immune and inflammatory cells and additional proteinases that contribute to 
emphysema have subsequently been identified. 
INFLAMMATION AND EXTRACELLULAR MATRIX PROTEOLYSIS  
 On exposure to oxidants from cigarette smoke, macrophages in the lower 
air space become activated, producing proteinases and chemokines that attract 
other inflammatory cells via oxidant-induced inactivation of histone 
deacetylase-2, shifting the balance toward acetylated or loose chromatin, 
exposing nuclear factor B sites and resulting in transcription of matrix 
metalloproteinases, proinflammatory cytokines such as interleukin 8 (IL-8), and 
tumor necrosis factor (TNF). This leads to recruitment of neutrophils. CD8+ T 
cells are also recruited in response to cigarette smoke and release interferon 
inducible protein-10 (IP-10, CXCL-7) that in turn lead to production of elastase 
by macrophages (Matrix metalloproteinase-12). Matrix metalloproteinases and 
serine proteinases, most notably neutrophil elastase, work together by degrading 
the inhibitor of the other, leading to lung destruction. Proteolytic cleavage 
products of elastin also serve as a macrophage chemokine, fueling this 
destructive positive feedback loop. Autoimmune mechanisms promote the 
progression of disease. Increased B cells and lymphoid follicles are present in 
patients with advanced disease. Antibodies have been found against elastin 
fragments. IgG auto antibodies with more affinity for pulmonary epithelium and 
the potential to mediate cytotoxicity have been detected. 
            Concomitant cigarette smoke–induced loss of cilia in the airway 
epithelium and impaired macrophage phagocytosis predispose to bacterial 
infection with neutrophilia. In end-stage lung disease, long after smoking 
cessation there remains an exuberant inflammatory response, suggesting that 
mechanisms of cigarette smoke–induced inflammation that initiate the disease 
differ from mechanisms that sustain inflammation after smoking cessation. 
  Air space enlargement with loss of alveolar units obviously requires 
disappearance of both extracellular matrix and cells. Cell death can occur from 
increased oxidant stress both directly from cigarette smoke and from 
inflammation. Animal models have used endothelial and epithelial cell death as 
a means to generate transient air space enlargement. Uptake of apoptotic cells 
by macrophages results in production of growth factors and dampens 
inflammation, promoting lung repair. Cigarette smoke impairs macrophage 
uptake of apoptotic cells, limiting repair. 
           The ability of the adult lung to repair damaged alveoli appears limited. It 
is unlikely that the process of septation that is responsible for alveologenesis 
during lung development can be reinitiated. The capacity of stem cells to 
repopulate the lung is under active investigation. It appears difficult for an adult 
human to completely restore an appropriate extracellular matrix, particularly 
functional elastic fibers. 
Clinical Presentation: 
History: 
 The three most common symptoms are cough, sputum production. 
Activities involving significant arm work, particularly at or above shoulder 
level, are particularly difficult for patients with COPD. In the most advanced 
stages, patients become breathless after  doing simple activities of daily living.  
 
 
 
 
GUIDE TO RATING SEVERITY OF CHRONIC OBSTRUCTIVE 
PULMONARY DISEASE (COPD)  
 Mild Moderate Severe 
typical 
symptoms few symptoms increasing dyspnoea 
dyspnoea on 
minimal exertion 
  breathlessness on moderate exertion 
breathlessness 
walking on level 
ground 
daily activities 
severely curtailed 
  little or no effect on daily activities 
cough and sputum 
production chronic cough 
    infections requiring steroids   
lung function FEV1 ≈ 60-80% predicted 
FEV1 ≈ 40-59% 
predicted 
FEV1 < 40% 
predicted 
 
Physical Findings: 
In the early stages of COPD, patients have a normal physical 
examination. Current smokers may have signs of active smoking such as an 
odour of smoke or nicotine staining of fingernails. In severe disease, there is 
prolonged expiratory phase with expiratory wheezing. Signs of hyperinflation 
include a barrel chest and enlarged lung volumes with poor diaphragmatic 
excursion as assessed by percussion. Patients with severe airflow obstruction 
may also exhibit use of accessory muscles of respiration, sitting in the 
characteristic "tripod" position to facilitate the actions of the 
sternocleidomastoid, scalene and intercostal muscles. Patients may have 
cyanosis that is visible in the lips and nail beds. Pink puffers," are thin and 
noncyanotic at rest and have prominent use of accessory muscles. Patients with 
chronic bronchitis are more likely to be heavy and cyanotic ("blue bloaters). 
Most patients have elements of both bronchitis and emphysema and that the 
physical examination does not reliably differentiate the two entities. 
Advanced disease may be accompanied by systemic wasting, with 
significant weight loss, bitemporal wasting, and diffuse loss of subcutaneous 
adipose tissue. This syndrome has been associated with both inadequate oral 
intake and elevated levels of inflammatory cytokines (TNF). Such wasting is an 
independent poor prognostic factor in COPD. 
 
Laboratory Findings: 
The characteristic feature of COPD is airflow obstruction. Pulmonary 
function testing shows airflow obstruction which is more for expiration than 
inspiration, with resultant increased work of breathing. 
There is reduction in FEV1 and FEV1/FVC. With worsening disease 
severity, lung volumes may increase resulting in an increase in total lung 
capacity, functional residual capacity, and residual volume. In patients with 
emphysema, the diffusing capacity may be reduced, reflecting the lung 
parenchymal destruction characteristic of the disease. There is decrease in 
maximum expiratory flow rates and uneven ventilation. The degree of airflow 
obstruction is an important prognostic factor in COPD and is the basis for the 
Global Initiative for Lung Disease (GOLD) redundant classification.  
           A multifactorial index incorporating airflow obstruction, exercise 
performance, dyspnea, and body mass index is a better predictor of mortality 
rate than pulmonary function alone. 
SPIROMETRY 
It means ‘‘the measuring of breath’’. This is a test for dynamic 
ventilatory functions of lung. The spirometer is an instrument used for these 
tests and the procedure is called spirometry. It is an essential tool in the hands of 
the physician to aid in the evaluation, diagnosis, and management of respiratory 
disorders. Graphical recording of spirometry is called spirogram. 
Types of spirometer 
A. Volume-Displacement spirometers  
B. Flow sensing spirometers or Pneumotachometer 
 Flow sensing spirometers are portable, easy to maintain and is most 
widely used. Portable flow sensing spirometer working on the infra red 
interruption principle was used in the present study to categorize the patients 
into different stages. 
 The patient is asked to take the deepest breath they can, and then exhale 
into the sensor as hard as possible, for as long as possible, preferably at least 6 
seconds. Soft nose clips may be used to prevent air escaping through the nose. 
Filter mouthpieces may be used to prevent the spread of microorganisms. 
PULMONARY FUNCTION TESTS  
 Various pulmonary function tests are being carried out to make proper 
assessment of lung function non invasively. Pulmonary function tests aim at 
assessing the various aspects of ventilation, diffusion and perfusion. 
I) Ventilation related parameters  
Lung volumes and capacities. 
II)  Ventilation–Perfusion related parameters 
a. Pulmonary blood flow. 
b. Ventilation/ perfusion ratio. 
III) Diffusion related parameters 
a. Diffusing capacity of lung for oxygen (DLO2). 
b. Diffusing capacity of lung for carbon monoxide (DLCO).  
IV) Tests for Mechanics of Breathing 
 a. Elastic resistance (Compliance and Elastance). 
 b. Non-elastic tissue resistance. 
 c. Airway resistance. 
 Pulmonary function tests were performed using a dry spirometer device 
(Erich Jaeger Gmb H, Hoechberg, Germany) after inhaling salbutamol 
(Ventolin, GlaxoSmithKline, London, UK) as classification of severity of COPD 
in GOLD guidelines is based on post bronchodilator FEV1. Each subject 
underwent a forced spirometry to obtain the following parameters: 
Forced vital capacity (FVC), 
Forced expiratoryvolumein1s (FEV1)and 
FEV1/FVC ratio. 
Subjects with FEV1 higher than 50% predicted but lower than 80% 
predicted were classified as the mild-to-moderate group; subjects with FEV1 
lower than 50% predicted were classified as the severe group  according to 
Global Initiative for Chronic Obstructive Lung Disease 2010 criteria. FEV1 
value is a powerful predictor of mortality. Also FEV1/FVC and FEF25 were 
found to be the best predictors of  longitudinal decline in lung function in men. 
Blood gases analysis is a better predictor of mortality rate than pulmonary 
function . 
GOLD-TABLE 
1) Mild: Post-bronchodilator FEV 1 ≥ 80% predicted 
2) Moderate: Post-bronchodilator FEV 1 ≥ 50% but <80% predicted 
3) Severe: Post-bronchodilator FEV 1 ≥ 30% but <50% predicted 
4) Very Severe: Post-bronchodilator FEV 1< 30% predicted 
Lung Volumes and Capacities 
Static volumes: 
Tidal volume: 
  It is the volume of air that moves in and out of the lungs during normal 
quiet breathing. It is about 500ml. 
Inspiratory reserve volume (IRV): 
It is the amount of air that can be inspired above the tidal volume by  
maximum effort. It is about 2500ml. 
Expiratory reserve volume: 
It is the amount of air that be forcefully expired above the normal tidal 
 expiration. It is about 1100ml. 
Residual volume: 
It is the amount of air that remains in the lungs after a maximal voluntary 
expiration. The lungs are not completely emptied of air because the distal 
airways collapse with air trapped inside due to increase in external pressure. 
Residual volume can be expelled only by opening the thoracic cage and causing 
collapse of the lungs. It is about 1200ml. 
The lungs are not completely emptied of air even after complete collapse 
because of the air trapped inside the alveoli. This is the minimal volume or 
minimal air. This air makes the lung tissues to float in water (Swammeredam, 
1664). 
Closing volume: This is the volume at which the peripheral small 
airways begin to close during a forced expiration. This occurs when 10% of the 
vital capacity is left in the lungs. Closing volume is increased in obstructive 
lung disease. 
Dynamic volumes: 
Respiratory minute volume (pulmonary ventilation): 
This is the volume of air that is inspired or expired during one minute. At 
rest it is about 6 litres. 
 Maximum voluntary ventilation: 
It is the maximum amount of air that can be moved in or out of the lungs 
by voluntary effort. It is about 125-170 L/min. 
Static capacities: 
Vital capacity: Forced vital capacity (FVC): 
 It is the maximum volume of air that can be expelled rapidly by maximal 
effort following a deep inspiration. (It is equal to tidal volume + Inspiratory 
reserve volume + Expiratory reserve volume). It is about 3.5 – 5.5 litres. It is a 
good index to assess pulmonary function and strength of the muscles of 
respiration. 
Inspiratory capacity:  
 It is the maximum amount of air that a person can breathe in by forced 
inspiration after a normal expiration. It is about 3000ml. 
Functional Residual capacity (FRC): 
It is the volume of air in the lungs at the end of quiet expiration. It is 
about 2500ml. The FRC acts as a buffer against fluctuations in PaO2 and PaCO2 
in the respiratory cycle, enabling continuous gas exchange. It reduces the load 
on the respiratory system and the left ventricle. 
Total Lung Capacity (TLC): 
It is the volume of air that is present in the lungs after a deep, maximal 
inspiration. It is about 4500 - 6000ml. 
Dynamic capacities: 
Timed vital capacity- FEV1:                                                                   
 It is the forced expiratory volume in the first second. This is the fraction 
of the FVC expelled in the first second during a forced expiration. In a normal 
individual 80-85%of the FVC is expired in the first second (FEV1), 95% in two 
seconds (FEV2) and 97-100% in three seconds (FEV3). It is reported as volume 
in litres, even though it denotes volume over a specific time. 
FEV1%:  
 FEV1 expressed as a percentage of FVC gives FEV1%. 
FEV1% = FEV1/FVC X 100. 
Normal Values: 
 Young adults : 80-85%. 
 Elderly people : 70-80%. 
 Children : >90%.   
 In restrictive lung disorders, FVC & FEV1 are reduced. FEV1% is normal 
or even above normal. 
 In obstructive lung disorders FEV1 is reduced and FVC is very much 
reduced. So FEV1% is also reduced. 
Maximum Mild Expiratory Flow Rate (MMEFR) or Mean Forced 
Expiratory Flow 25-75% (FEF 25-75%): 
 This is the mean flow rate achieved during the middle 50% of FVC. This 
indicates the patency of small airways. 
Maximal Expiratory Flow Volume (MEFV) Curves and Maximal Forced 
Expiratory Flow Rates: 
 It is a graphical representation of maximum flow rate against lung 
volume during FVC performance. The values derived are FEF25, FEF50 and 
FEF75. It is helpful to differentiate between central and peripheral airway 
disease. 
Peak Expiratory Flow Rate (PEFR): 
 This is the rate of maximum airflow out of the lungs which is sustained 
for 10 milliseconds during a forceful sudden expiration following a maximum 
inspiration. It is expressed in litres per minute or litres per second. This is 
decreased in obstructive and restrictive lung disorders. 
Normal values: 
Age group 
PEFR (L/min) 
Male Female 
<40 years 400-650 250-450 
>40years 300-500 200-400 
 
Inspiratory Volumes and Flow rates: 
 Inspiratory Vital Capacity (FIVC), Forced Inspiratory Volumes and Flow 
Rates (FIV & FIF) and Maximum Inspiratory Flow Volume (MIFV) Curves can 
also be derived. They are useful in detecting extrathoracic airway obstruction.31 
Breathing Reserve or Dyspnoeic Index: 
 BR% = MVV – RMV/MVV X 100. 
 Normal breathing reserve is > 90%. 
COGNITION: 
 The term cognition is derived from the latin term `Cognoscere' meaning 
to know or to conceptualise which includes the functions involved in 
synthesizing information, that is perception, attention, memory, language, and 
reasoning. Cognition means knowledge or understanding. Cognitive functions 
decide our success, competence and healthy living. Cognitive psychology is 
more scientific, and seeks highly specific and detailed answers to precise 
questions, concerned with conscious mental life, and studies inner processes. 
Cognition includes a wide range of human mental abilities. It is the third main 
area of human development in addition to physical and social development. 
Cognitive or mental development not only includes intelligence, but also 
complementary processes such as perceiving, recognizing, recalling and 
interpreting information as well as all forms of reasoning. Cognitive ability is 
usually broken down into domains concerning memory, learning ability, 
attention/concentration, abstract thinking, and problem solving.35 The thinking 
process occurs in the brain from the sensory input received, and the stored 
memory which brings on appropriate motor activity.  
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 Executive function is the function of dorsolateral prefrontal cortex. 
Executive functions play a role in planning and initiation of independent 
activities, self monitoring, and performance, switching between tasks, inhibition 
of inappropriate responses and planning complex motor and problem solving 
responses36. Although prefrontal cortex has long been explained as a substrate 
for executive functions, more recent and advanced research has led to the 
discovery of increased role played by extreme interconnections between 
subcortical and cortical regions of brain. Executive functions are key to our 
capacity, formulating our goals, planning and organising such goal directed 
behaviours, carrying out such behaviours fully and effectively and monitoring 
and self correcting ones behaviour as needed37 
Attention or Vigilance is the ability to maintain attention over time. 
Verbal learning and memory is the ability to learn more information, to retain 
newly learned information over time, and recognising previously presented 
material. Verbal fluency is the ability to produce as many words as possible. 
Immediate or Working memory is the ability to hold a limited amount of 
information for a brief period of time. Working memory is the core component 
of neurocognition, which is mediated by prefrontal cortical regions. 
Development of thought in a child was studied by Jean Piaget in 20th C, an 
eminent Swiss epistemologist. 
Knudsen38 describes a model which shows four processes of attention 
with working memory in the centre. 
1. Working memory temporarily stores information for analysis. 
2. Competitive selection that determines which information goes to working 
memory. 
3. Top-down sensitivity control by the content of working memory which 
influences the selection of new information. This results in voluntary 
control of attention in a recurrent loop – endogenous attention 
4. Bottom-up filters which automatically enhance the response to infrequent 
stimuli    – exogenous attention.  
The term "working memory" was coined by Miller, Galanter 
and Pribram.39 Most working memory tasks recruit a network of prefrontal 
cortex and parietal areas. During a working memory task, the connectivity 
between these areas increases.40 
Working memory is a special short term memory store. It has three 
component systems (Baddley and Hitch model):  
a) Attentional control system: It focuses on perception of specific 
happenings in the environment. It is located in the prefrontal cortex and 
has very limited capacity. It regulates the flow of information to two 
rehearsal systems which are thought to sustain memory  for temporary 
use. 
b) Rehearsal systems- Articulatory loop: It refers to a storage system with 
a quickly fading memory trace. Here, memory for numbers and words 
can be sustained by subvocal speech e.g remembering a new mobile 
number as a person prepares to dial it. 
c) Visuo-spatial sketch pad: It represents both the spatial location  and the 
visual properties  of object to be remembered. For example, this system 
allows a person to store the image of  an individual’s face whom he met 
at a dinner party. 
 The two rehearsal systems are situated in the posterior association areas. 
The information processed in either of these systems has the possibility of 
reaching long term memory. The cognitive state examination includes 
orientation, attention, concentration, memory, general information, ad 
intelligence. 
NEUROPSYCHOLOGICAL TESTS 
Mini Mental State Examination (MMSE): 
MMSE (FOLSTEIN et al., 1975)41 takes 5-10 mins to administer and 
test retest reliability is high. It provides a rough and ready index of cognitive 
functioning. First part covers orientation, attention, concentration and memory. 
Second part tests the ability to name common objects, follow verbal or written 
commands, write a sentence spontaneously and copy a simple figure (eg: 
overlapping pentagons) - visuospatial testing. 
The  total score  is 3042,  scores less than 24 indicates cognitive 
impairment.  
Stroop Test: (Stroop Color and Word Test) 
The basic aspect provided by the Stroop is that it has been associated with 
cognitive flexibility, resistance to interference from outside stimuli,  creativity, 
psychopathology, and cognitive complexity. It clearly plays a role in many 
interrelated cognitive processes which determine an individual's ability to 
successfully cope with cognitive stress and to process complex input (Golden, 
1978). 
Inhibitory processing is the efficiency of the inhibitory process that 
underlies selective attention. Inhibition allows a reduction of irrelevant 
information to enter  working memory (Hasher & Zacks, 1988). The area of the 
brain which is usually affected by inhibition is the frontal lobe. The test 
involves multiple areas including knowledge, attention, visual scanning and 
acuity. As the impairment in executive function severely affects the quality of 
life, the rehabilitation measures should be directly targeted on management of 
executive functions after quantifying the problem (Crawford 2000)43. John 
Ridley Stroop (1935) worked on the interference that can arise between word 
reading and colour naming. It takes longer time to read printed colour names 
when they are printed in coloured ink different from that of the coloured word. 
This may be due to 
           1) response conflict  
           2) failure of response inhibition 
           3) failure of selective attention. 
The increase in time taken to perform the second task compared with the 
first task is referred to as “the  Stroop interference effect” (e.g., Davidson, 
Zacks, & Williams, 2003; Moering, Schinka, Mortimer, & Graves, 2003). It 
gives selective attention, cognitive flexibility and control, self correction and 
speed of processing (Uttl & Graf, 1997) or executive functioning (Moering et 
al., 2003). 
Slowing with age has been consistently documented (Hasher & Zacks, 
1988; Obler and Albert, 1985; Spreen and Strauss, 1991). The results also 
reinforce the slowing due to decreased oxygen supply to the brain as identified 
in those with COPD (Clark).  
COGNITIVE EVOKED POTENTIAL STUDY 
Evoked potentials refer to the action potentials generated from central 
nervous system in response to a specific and adequate stimulus. They are small 
and are buried in the background of spontaneous electrical activity (EEG). Their 
details can only be studied and evaluated by repeated stimulation and averaging 
the responses obtained after each stimulation. Evoked potentials have evolved 
from a challenging scientific technique to a commonly applied tool in the 
neurophysiology in the last few decades44. They establish objective evidence of 
abnormality when signs and symptoms are equivocal. 
 Evoked potentials are classified into  
1. Stimulus related potentials 
2. Event related potentials (ERP) or Endogenous potentials 23 
Stimulus related potentials:   
They are generated in response to an exogenous stimulus – visual, 
auditory, and somatosensory. They depend on the physical characteristics of the 
stimulus. Commonly used stimulus related potentials are brainstem evoked 
response audiometry, visual evoked potential and somatosensory evoked 
potential. 
Event related potentials: 
In 1935-1936, Pauline and Hallowell Davis recorded the first known 
ERPs on awake humans. In 1964, Grey Walter and colleagues reported 
cognitive ERP component, called the contingent negative variation (CNV). 
Sutton, Braren, and Zubin (1965) made advancement with the discovery of 
the P3 component. In 1980s, the introduction of inexpensive computers opened 
up a new door for cognitive neuroscience research. Currently, ERP is one of the 
most widely used methods in cognitive neuroscience research to study the 
physiological correlates of sensory, perceptual and cognitive activity associated 
with processing information. 
Over the past few decades, electrophysiology has contributed 
substantially to the understanding of normal as well as abnormal brain function 
deviations in psychopathological conditions. Electrophysiological techniques 
enable the study of the physiology of  brain's systems with a high temporal 
resolution, providing the best methods to describe the time course of brain-
electrical activation during complex cognitive processes (such as conscious 
sensory discrimination or semantic processing). They are elicited when the 
subject is required to distinguish one stimulus (the target) from the other (non- 
target). Since ERPs are related to cognitive processing associated with the 
distinction of target from non-target stimuli, they are also called cognitive 
evoked potential. ERPs are also referred to as P300, because they occur after a 
latency period of approximately 300 milli seconds,45,46. ERPs are independent of 
the physical characteristics of the stimulus. When a stimulus is presented to the 
brain, it travels through the receiving sensory organ and the brainstem (except 
for visual and olfactory stimuli) on its way to the primary cortical regions 
mediating this particular sensory modality. ERPs recorded over primary sensory 
cortex indicate how the stimulus was received and recorded by the brain, 
thereby providing an index of the integrity of the underlying neural architecture. 
For instance, the early waves arising immediately after (within about 15 ms) an 
auditory stimulus are referred to as the brainstem auditory evoked potential. 
These components reflect the intactness of the pathways that they traverse, are 
useful for the diagnosis of sensory defects (such as hearing loss), and thus are of 
great interest to neurologists. 
 Once received by the brain, a stimulus undergoes psychological 
processing and evaluation, and these operations are reflected in later ERP waves 
that are distributed to various scalp locations. These components are influenced 
by levels of arousal and attention as well as the informational content and 
salience of the stimulus. These long latency evoked potentials are related to 
cognitive processing and so are called as cognitive evoked potentials, event 
related potential, P3, P300 or endogenous EP. Because many of these components 
have been shown to be sensitive to particular experimental manipulations, 
various paradigms have been developed to facilitate the study of specific 
waveforms. An event-related potential (ERP) is the measured brain response 
that is the direct result of a specific sensory, cognitive, or motor event. It is any 
stereotyped electrophysiological response to a stimulus. It  provides a 
noninvasive means of evaluating brain function in patients with cognitive 
diseases.  
The characteristic features of ERPs are, 
1) They are elicited by endogenous stimuli 
2) Requires attention and patients cooperation 
3) They have a longer latency, higher amplitude, and lower frequency 
of waveform. 
4) They are not influenced by frequency and intensity of stimuli   
They are less bound by the physical properties of a stimulus than sensory 
ERPs. The characteristics of late waves reflect individual differences in how the 
stimulus interacts with and affects the person. Various features of ERP have 
been found to be highly heritable, indicating that they capture stable individual 
differences in electrophysiology. Late ERP components also have been shown 
to be deviant in many clinical and psychiatric conditions and thus are of 
considerable interest for their potential as clinical tools. The P300 is best 
recorded with an analog high-pass filter set at 0.1 Hz  or less47 
Ocular Artifacts:  
 Electrical potentials generated by eye movements and blinks are a major 
problem when recording the P300 wave. Subjects are instructed not to blink or 
move their eyes unless absolutely necessary. The P300 wave is usually measured 
in terms of a peak amplitude relative to a prestimulus baseline and a peak 
latency relative to the stimulus onset. The peak is usually identified as the most 
positive point in the waveform between 200 or 250 ms and some later time. 
  The measurements are usually taken at one electrode location, typically 
either cz or pz. The latency of the P300 wave varies from one electrode location 
to the next, usually being earlier at more frontal locations and the amplitude of 
the P300 wave varies with the amount of conscious attention paid to a stimulus. 
The P300 wave generally occurs only in response to task-relevant stimuli. The 
amplitude of the P300 wave was inversely proportional to the probability of 
each tone. 
 Goodin et al. (1978a) reported that the latency of P300 wave in an 
auditory oddball paradigm was significantly related to the age of subjects 
between 18 and 76 years. 
In general, the amplitude of the P300 is smaller in older subjects and it 
increases with increasing age until about 13yrs, after which it may decrease 
slightly to normal adult values (polich). The P300 wave is not generated in one 
place. It may represent concurrent activity in multiple regions of the brain. 
 The regions of the brain most involved in this interactive process would 
be the polymodal association areas of the frontal, parietal, temporal lobes and 
the limbic system. 
 A normal P300 wave may therefore indicate that a subject is cognitively 
processing the evoking stimulus. This may be helpful in demonstrating the 
brain's ability to discriminate between stimuli in cases of functional sensory 
impairment. If the P300 wave is abnormally small or delayed, there is probably 
some abnormality of cognitive processing. Latency is a much more reliable 
indicator than amplitude, since latency is difficult to alter with attention. 
Furthermore, the normal limits for latency are less broad than the normal limits 
for amplitude. The use of the P300 latency to demonstrate cognitive dysfunction 
is important in such conditions as early dementia or the cognitive dysfunction 
that occurs with metabolic disorders have higher amplitude and lower frequency 
compared to the stimulus related potentials.  
 Physiological Basis of Waves 
Any stimulus like auditory, visual, olfactory, somatosensory or pain can 
be used for eliciting cognitive potential. Auditory stimuli are most frequently 
used in clinical practice. The stimuli are delivered using standard odd ball 
paradigm where two types of stimuli: target (infrequent) and non-target 
(frequent) are used. The target stimuli comprise 15 – 20 % of total stimuli, 
which appear randomly. The character of target stimuli differs from the 
common stimuli in terms of frequency or intensity. The patient is asked to count 
mentally or raise the finger or press a button in response to target stimuli. This 
specific intellectual function produces discrete waveforms of cognitive evoked 
potential. 
 ERPs are wave patterns with 3 parameters 
1) Polarity 
2) Latency 
3) Scalp distribution 
Amplitude (µV) is the difference between the mean prestimulus baseline 
voltage and the largest positive or negative peak of the ERP waveform within a 
time window. 
 Latency (ms) is the time from stimulus onset to the point of maximum 
amplitude (Polish, 2007). The positive and negative wave forms are designated 
as P and N respectively followed by approximate latency in milli seconds. 
There are two negative waves, N100 and N200 and two positive waves, P200 and 
P300 (fig:5). These waves reflect specific cognitive processes. The N 100 and P 200 
waves are considered to reflect early attention capacities related to stimulus 
processing48. The N 200 wave is regarded as an index of stimulus detection49.The 
P300 wave reflects a later, more controlled and voluntary decision making 
capacity and memory50. 
The P300 wave is the most frequently investigated ERP. It is related to the 
maintenance of working memory (Donchin and Coles, 1988). P300 reflects the 
mnemonic and cognitive function in humans51,52, information processing53, and 
seems to be strongly associated with short term memory54. 
FIGURE : 5 
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 Generators of P 300: 
 Different areas of the brain such as inferior parietal lobule, frontal lobe, 
hippocampus, median temporal lobe, insula and other limbic structures are 
involved in generation of P30023. The involvement of dopaminergic system at 
these sites in the generation of P 300 is well documented55. 
P 300 Latency And Amplitude: 
 There are two ways of measuring P 300 latency 23 
1. Point of maximum P 300 amplitude 
2. Intersectional extrapolation – The ascending and descending limbs of P 
300 wave are extended to the point of intersection which is measured as P 
300 latency. 
The amplitude of P 300 wave is measured from pre stimulus base to peak 
or peak to peak from N200 wave. Generally P 300  amplitude decreases as the 
latency increases56. 
VARIABLES AFFECTING P 300 
1. Attention  
Decrease in alertness is associated with reduction in amplitude57.  
Drowsiness or inattention decreases P 300 amplitude or may even obliterate it. 
However P300 can be recorded in stage II sleep, but disappears in slow wave 
sleep58. P300 amplitude increases with correctly recognised stimuli compared to 
incorrect ones55. 
2. Age 
The P300 latency increases as age increases. There is increase in mean 
latency by about 1 – 1.5 milli second per year after the age of 20 years (Goodin 
et al1978a)59. P300 is lowest in the age group 15 – 25 years60. The amplitude 
decreases after the age of 80 years. 
3. Body mass index 
Prolonged P300 latency and decreased amplitude was observed in obese 
individuals by Tascilar et al61 . 
4. Drugs 
Anticholinergics and antihistaminics increase P300 latency and reduce its 
amplitude (Callaway, 1984; Hammond et al.,1987; Meader et al., 1989)62. 
Physostigmine can reverse the effect of anticholinergic on P300. 
5. Technical Parameters  
 
Stimulus intensity generally does not influence P300, but a markedly high 
intensity may reduce P300 latency63. P300 amplitude increases as the target 
stimulus frequency in the global sequence decreases64. Use of high pass filter of 
1 Hz may decrease P300 latency and amplitude compared to lower frequency 
high pass filters65. 
Clinical application of P300 : 
A normal P300 indicates that a subject is cognitively processing the 
evoking stimulus. Goodin et al66 were the first to show that P300 latency delay 
might provide a specific and sensitive marker for dementia. If P 300 is small or 
late it indicates defective cognitive processing. The latency is a more reliable 
indicator than the amplitude67. It is an indicator of subclinical 
encephalopathy. P 300 is an objective tool for detecting cognitive impairment68. 
 Clinical utility of P300 has been increased by identification of factors that 
lead to variability of P300 measurement. When appropriate standardised 
procedures are used, the P300 can prove to be a highly useful means to quantify 
cognitive capability. 
 Some important clinical applications of P300 are in dementia, cognitive 
disorders in children, encephalopathy, alcoholism, Parkinson’s disease, 
Huntington’s disease, HIV infection, Psychiatric disorders, Mental retardation, 
vitamin B12 deficiency, organophosphate poisoning, chronic liver failure and 
chronic renal failure. 
 
 
Function of P 300  
It is referred as Aha wave.  In the Neuroinhibition Hypothesis, since 
infrequent, low probability stimuli can be biologically important, it is adaptive 
to inhibit unrelated activity to promote processing efficiency thereby yielding 
large P300 amplitudes. Memory is updated after incoming information has been 
evaluated. Cognitive theory suggests that information is processed 
automatically which is fast and efficient,  mostly  by controlled processing 
which is slow, effortful, conscious, and serial. All consciously controlled 
responses occur after and simple responses occur automatically prior to P300. 
  
HYPOXEMIA : 
 The term Hypoxia means "oxygen levels which are below atmospheric 
concentration. This occurs when the inspired oxygen concentration is low, 
thus resulting in “ hypoxaemic hypoxia” or when the general barometric 
pressure is low it is called “hypobaric hypoxia”. Mild hypoxia - partial pressure 
of oxygen (PaO2) is above 50mmHg, at this level there is complete 
compensation and general function is barely altered. Partial pressure of oxygen 
between 35 and 50 mmHg is moderate hypoxia, a state which leads to variable 
findings in cognition. When PaO2 is below35mmHg (severe hypoxia), there is 
loss of conscienceness. Moderate and severe hypoxia can result in variable 
neuronal loss depending on the severity and length of exposure."69. 
Pathophysiological Changes in Central Nervous System Due to Chronic 
Hypoxia:  
Cerebral hypoxia depends on, the severity, duration, speed of onset, and 
progression of illness70. Chronic Hypoxia corresponds to the time required to 
trigger a physiological response. It can be from weeks to months71. Some 
patients who have normal oxygen saturation may experience hypoxic episodes 
after exercise72,73, during sleep or during daily activities.74,75. The respiratory and 
sympathetic responses are the adaptation procedures leading to changes in 
signalling pathways, in neuromodulators, and their receptors, and in the 
genomic effects. Vascular adaptations is  by PaO2, Hb concentration, and Hb 
saturation by, increased ventilation, pulmonary vasoconstriction, increased 
production of red blood cells. Polycythemia increases the oxygen carrying 
capacity of blood and shifts the oxygen dissociation curve to right. 
Cerebral blood flow is increased by neuronal pathway from brain stem 
and by local tissue factors like nitric oxide, adenosine, potassium ions etc and 
are closely linked to blood oxygen concentration76,72,78,79,80 . 
In response to hypoxia, encephalic neurons lower the metabolic rate and 
short and long term adaptation come into play. Depolarisation of potassium, 
calcium and sodium channels lead to higher cell excitability. 
  
COGNITION IMPAIRMENT IN COPD  : 
In recent decades, several studies have demonstrated the presence of 
cognitive impairment (Huppert F, GrantI, Prigatano, Fix, Incalzi, Vos PJE, 
Fioravanti M, Stuss DT, Kosaro E, Leisker JJ, Ozge, C Ozge, Lima OM). 
Lung diseases causing cognitive impairment due to chronic hypoxia has 
been studied  and the common cognitive abnormalities observed were 
memory impairment81,82,83, verbal language loss,76 attention 
disturbance,
81,83,84,85,86,87 
dys-executive syndrome,
86,87,88,80 
and difficulties in 
abstract thinking81  were found. 
  Low forced expiratory volume of first second (FEV1s) and forced vital 
capacity (FVC) are prognostic parameters of cognitive impairment in COPD.89 
The majority of both national and international literature on effect of hypoxia 
on cognitive effects in patients with chronic lung disease, points to sub cortical 
type mild cognitive impairment with decline in attention, slower mental speed 
and compromised executive functions90. 
 Lesions  are found in frontal-subcortical pathways or in subcortical 
structures linking to the frontal lobes.91,92 Attention and decision-making circuits 
involve pre-frontal cortex, thalamus, nucleus accumbens and heteromodal 
cortices (frontal, parietal and occipital) as well as paralimbic associated areas. 
The main neurotransmiter is acetylcholine, also serotoninergic and 
dopaminergic pathways.  
 There is evidence of low acetylcholine concentration in the neocortex, 
hippocampus, striate nucleus and septal area, as well as dopamine in neocortex 
and hippocampus of mice submitted to the same conditions.88 This is explained 
by the relative reduction in acetylcholine synthesis and other aminoacids due to 
lower carbohydrate oxidation in mild chronic hypoxia.93-95  Decrease in sodium 
and potassium ion gradients which occur in chronic hypoxia conditions affects 
acetylcholine transport to neurons, lowering its uptake by the post-synaptic 
neuron.
96 
It produces its effect through tissue hypoxia. Body tissues vary 
considerably in their vulnerability to hypoxia those with the greatest need of 
oxygen are the brain and the heart. 
If PO2 of the tissues fall below a critical level, aerobic metabolism ceases 
and anaerobic metabolism takes over and there is accumulation of lactic acid 
leading to metabolic acidosis. Mild hypoxemia produces few manifestations like 
slight impairment of mental functions. More pronounced hypoxemia produces 
personality changes, impaired judgement due to cognitive impairment. The 
manifestations of chronic hypoxia is insidious in onset and it is due to chronic 
lung disease97. Diagnosis is based on clinical observation and diagnostic 
measures of PO2 levels. Arterial blood gas analysis gives the direct measure of 
O2 content of the blood. Non invasive measurements of arterial oxygen 
saturation of oxygen haemoglobin can be obtained by using Pulse Oximeter, 
which is an useful indicator of respiratory and circulatory status.  
Arterial blood gases and pulse oximetry demonstrate resting or 
exertional hypoxemia. Arterial blood gases provide additional information 
about alveolar ventilation and acid-base status by measuring arterial PCO2 and 
pH. The change in pH with PCO2 is 0.08 units/10 mmHg acutely and 0.03 
units/10 mmHg in the chronic state. Knowledge of the arterial pH therefore 
allows the classification of ventilatory failure, defined as PCO2>45 mmHg, into 
acute or chronic conditions. The arterial blood gas is an important component of 
the evaluation of patients presenting with symptoms of an exacerbation. There is 
a subtle balance between central nervous system functioning and the pulmonary 
system.89  Even  small changes can have a major impact.90 Hypoxia and 
hypercapnia in acute or chronic respiratory insufficiency  can result in a myriad 
of neurological and neuropsychological signs and symptoms. 
 
 
 
 
 
FIGURE – 6 
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PULMONARY REHABILITATION: 
This refers to a treatment program that incorporates education for 
cognition  and is necessary for cardiovascular conditioning. In COPD, 
pulmonary rehabilitation has been demonstrated to improve health-related 
quality of life, dyspnea, and exercise capacity. It has also been shown to reduce 
rates of hospitalization over a 6- to 12-month period. 
 Cognitive Evoked Potential in Animal studies: 
In animal studies, odd ball paradigm was associated with a reinforcement 
either an electric shock (O’C onnor and Starr 1985), a juice reward (Paller et al) 
or a passive odd ball paradigm (Pinida et al 1988).  Also the areas of the brain 
active during P300  were studied. In cats, activity was recorded in the thalamus, 
hippocampus, auditory cortex, and association cortex. In monkeys, activity has 
been recorded in the hippocampus. P300 has been demonstrated in tectum and 
retina of fish (Bullock et al). Many studies also evaluated the effects of lesions 
to different brain regions on P300. Most of the study findings were negative. 
Even though there were lesions, P300 wave was still present.  
In many studies (Fix AJ 98 et al, Grant I et al 14, Stuss D T et al84, 
Fioravanti M et al 111 etc.,), cognitive impairment was found in COPD patients. 
They used a battery of neuropsychological tests to assess cognition. Recall was 
the important domain to be affected in COPD patients along with decline in 
verbal memory. Kozora et al112 (1999), in his study found that the COPD 
patients performed significantly worse than  the controls on verbal fluency 
tasks.  
Incalzi RA et al81 in his study, showed that 48.5% of patients with 
COPD had a specific pattern of cognitive deterioration characterized by a 
dramatic impairment in verbal memory tasks,  and diffuse worsening of the 
other functions 
Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM14, 
studied the Neuropsychological findings in hypoxemic COPD patients in 1982. 
They showed that mild hypoxemia may be associated with impairment in higher 
cerebral functioning including abstract reasoning, auditory and visual attention, 
verbal and non verbal learning, recall, reasoning, and motor skills". 
Fix AJ, Golden  CJ,  Daughton D, KassI, Bell CW in 198298,                                            
showed that 64% of COPD patients included in their study scored less in 
MMSE, predominantly in recent memory, construction, attention, language, and 
orientation domains. Functional abnormalities were correlated with cognitive 
abnormalities". 
Prigatano GP, Parsons  O, Wright E, Levin DC, Hawryluk G. in 
198399, found that cognitive domains such as speed, coordination,  
memory and learning, intelligence and attention were significantly 
impaired in mild hypoxemic COPD patients which was correlated 
with partial pressures of oxygen".  
Stuss DT, PeterkinI, Guzman DA, Guzman C, Troyer AK in 199784. 
Studied the hypoxic effects on neurological and neuropsychological 
measures in Chronic obstructive pulmonary disease patients. This study 
states that there is significant relationship between blood arterial oxygen 
and carbon di oxide concentration and cognitive impairment. 
Incalzi RA, Gemma A,   Marra C,  Capparella O,  Fuso  L, 
Carbonin P. (1997) in their study"82, observed a  decline of verbal memory which  
parallels that of the overall cognitive function in COPD patients and was found 
to be due to the impairment of both active recall and passive recognition of 
learned material". 
Shim TS, Lee JH, Kim SY, Lim TH, Kim SJ, Kim DS, et al. in 
2001,100 states that cerebral metabolic abnormalities are observed in 
COPD patients which were detected by localized proton magnetic 
resonance spectroscopy.  
Liesker JJ, Postma DS, Beukema RJ, ten Hacken NH, Vander  
MT, Riemersma RA, et  al.86" in 2004 proved that COPD patients 
performed worse than the controls in speed, coordination, attention,  
and intelligence. 
Reeves RR, Struve FA, Patrick G, Payne DK, Thirstrup LL101  in 
their study on auditory and visual P300 cognitive evoked responses in patients 
with COPD and their relationship to the degree of pulmonary impairment found 
that auditory P300 latency significantly correlated with the FEV1/FVC ratio 
(indicating that increasingly severe airflow impairment is associated with longer 
auditory P300 latencies. Progressive impairment of the auditory P300 evoked 
potential latency occurs with increasing severity of COPD. This impairment is 
present even in patients with mild COPD, suggesting some degree of 
accompanying cognitive decline early in the course of COPD with worsening as 
the disease progresses. 
Hulya Ortapamuk, Seniha Naldoken in 2006 in their study1 0 2 on 
abnormalities in Brain perfusion in chronic obstructive pulmonary disease: 
comparison with cognitive impairment showed that the scores of verbal 
memory, delayed recall and vigilance were significantly lower in COPD 
patients. Hypoxemic patients showed more deterioration in cerebral perfusion 
and cognitive performance than non-hypoxemic patients. 
Raffaele AntonelliIncalzi, Antonella Gemma, Camillo 
Marra,  Rodolfo Muzzolon,  Oliviero Capparella, and Pierugo Carbonin104 
in their study on Chronic Obstructive Pulmonary Disease: "An Original Model 
of Cognitive Decline", test scores revealed that 48.5% of  COPD patients had a 
specific pattern of cognitive deterioration characterized by a remarkable verbal 
memory impairment and visual attention was well-preserved with worsening of 
the other functions". 
  
 
  
  
 Aim and objectives  
AIM AND OBJECTIVES 
 The  aim of the present study is to assess cognition in stable COPD 
patients  and to correlate cognition  with their blood oxygen levels.  
The objectives of the study were   
1. To assess cognition  in Stable COPD patients using  MMSE, Stroop test 
(Neuropsychological tests) and the Cognitive Evoked Potential  study 
(neurophysiological test).  
2. To measure  Arterial oxygen saturation (SpO2)  by  using Pulse oximetry 
in Stable COPD patients.  
3. To measure  Partial pressure of Oxygen in Stable COPD patients  by 
Arterial Blood gas analysis.   
4. To correlate Blood  Oxygen levels with  Cognition  in  stable COPD 
patients.  
5. To assess cognition and measure arterial oxygen saturation by Pulse 
Oximetry in age matched controls. 
 
  
  
 Materials & methods  
MATERIALS AND METHODS 
50   Stable COPD patients were selected on the basis of modified criteria 
defined in Global initiative for Chronic Obstructive Lung Disease (GOLD) 
guidelines.20  They were clinically stable and belonged to mild and moderate 
category. After eliciting detailed history, general examination was done. Then, 
Clinical examination of Respiratory system was done. Arterial oxygen 
saturation was assessed with Pulse oximetry. Cognitive function was assessed 
using a screening test Mini Mental State Examination and a neuropsychological 
test Stroop test, Cognitive Evoked Potential Study and the results were 
recorded. Arterial blood gas analysis  was done for patients. 
50 age matched controls from a similar background were recruited. After 
eliciting history, general examination, clinical examination of Respiratory 
system, they were subjected to assess cognition and pulse oximetry was also 
done  
STUDY DESIGN  :  Case control study 
TYPE OF STUDY : Comparative study 
PLACE OF STUDY: 
Neurophysiology Lab, Department of Physiology, 
Govt. Stanley Medical College. 
Chennai-1. 
DURATION OF STUDY : February 2014 to August 2014 
ETHICAL CLEARANCE  : 
 Obtained from Institutional Ethical  Committee,  
 Govt. Stanley Medical College 
Chennai- 1. 
SUBJECT SELECTION:  
STUDY    GROUPS: 
The study population consisted of 50 Stable COPD patients and 50 
controls.   
* CONTROL GROUP: The Control group  were recruited from the  
College and Hospital workers and construction workers who volunteered 
for the study. They were age matched and had same educational 
qualification and socioeconomic background. Healthy men in the age 
group above 40 years, with normal spirometry findings. Arterial oxygen 
saturation was measured  with pulse oximetry. 
* STABLE COPD PATIENTS: The patients were recruited from the 
Pulmonology outpatient department at Govt. Stanley Medical College 
Hospital, Chennai 1. Stable COPD patients were identified and diagnosis 
was based on GOLD guidelines i.e., cough, sputum production, and 
difficulty in breathing with H/O exposure to smoking  and spirometry 
results. They were above 40 years of age and in  Stage-I & Stage-II-stable 
course of disease  
Arterial Oxygen saturation was measured by Pulse oximetry. Arterial 
Blood Gas Analysis was  done 
EXCLUSION CRITERIA : 
1. Auditory dysfunction,  
2. Treatment H/O intake of any neurotoxic drug  
3. H/O any traumatic lesion possibly affecting auditory functions or central 
nervous system 
4. Cardiovascular or other systemic diseases 
5. H/O any cognitive impairment/neurological deficit/neuropathy  
6. Diabetes mellitus, 
7. Chronic Alcoholism,  
8. Chronic kidney disease and  liver disease 
9. Cystic fibrosis. 
10. Any major medical illness at present or within three months. 
11. Individuals with ear disease with hard of hearing 
12. Vitamin deficiency 
13. Individuals on psychotropic drug medications 
14. H/O drug abuse 
15. Persons with Overt Dementia (MMSE < 24) 
16. Sleep disorders, Obstructive Sleep Apnoea (OSA), 
All the subjects were explained about the nature and procedures involved 
in this study. The informed written consent from all the persons involved in this 
study was obtained.  
HISTORY TAKING 
The importance of demographic details is stressed while assessing 
cognition21,  smoking in pack years (20cigarrettes /day for 1 year =1 pack year), 
occupation  as  an  environmental factor was  also entered. 
In the stable COPD  patients, history regarding various symptoms were 
also recorded. 
CLINICAL EXAMINATION 
Height and weight were taken and Body mass index (BMI) was 
calculated. Vitals like pulse, blood pressure, respiratory rate and temperature 
were recorded. Complete general and systemic examination was done . ENT 
examination was also done.  
PULSE OXIMETRY 
Blood oxygen saturation (SpO2) was evaluated for all subjects while they 
breathed room air in the supine position. 
PULSE OXIMETRY PHOTOGRAPH-1 
 
  
 LUNG FUNCTION TESTS  
 They were  performed using a dry spirometer device (Easy  One).  All the 
COPD patients were  current smokers or ex-smokers. All were given proper 
instructions regarding the procedure. After inhaling salbutamol (Ventolin; 
GlaxoSmithKline; London, UK), spirometric indices were calculated using the 
best of  the  3 good performances as recommended by American Thoracic 
Society as Classification of severity of airflow limitation is based on Post 
Bronchodilator FEV1 as per GOLD Guidelines . The forced vital capacity 
(FVC), the forced expiratory volume in one second (FEV1), and FEV1/FVC 
ratio (FEV1%) were obtained22. 
FEV1≥ 80%  predicted were classified as mild COPD;  
FEV1 <80%  predicted were moderate COPD;  
FEV1<50%  predicted were severe COPD and  
FEV1<30% predicted were very severe COPD.  
Mild and moderate COPD patients were defined as mild-to-moderate 
COPD group, while severe and very severe COPD patients were defined as 
severe COPD group. Mild and Moderate COPD (Stable) patients were taken for 
the study. 
  
ARTERIAL BLOOD GAS ANALYSIS (ABG): 
Arterial blood gas analysis was performed by using  cobas b 121  model 
instrument in the central laboratory only for the patients at rest in supine 
position. The syringe was washed with Heparin and after confirming the 
patency of radial and ulnar artery by doing  Allens test. Radial artery pulsation 
was felt. The  needle was inserted and radial  arterial  sample o b t a i n e d  
during the mid-afternoon,  after a 15min rest. Once the sample is ready it is   
taken and ABG analysis is done without delay. The arterial oxygen tension 
(PaO2), arterial carbon dioxide tension (PaCO2) and blood oxygen saturation 
(SaO2) was evaluated for all subjects. Samples were  processed  by a Cobas b 
121 blood  gas   analyser (Ciba-Corning Ltd, Halstead, Essex,  UK). 
ARTERIAL BLOOD GAS ANALYSIS:PHOTOGRAPH-2 
 
 
 
 
 
 
 MINI MENTAL STATE EXAMINATION: 
MMSE was done to assess cognition in all the subjects  involved in this 
study .The following cognition domains were tested. 
ORIENTATION 
The individuals were asked simple questions to assess their orientation to 
person, place and time (year, month, day, date, time, country, town, district, 
hospital, floor).  
Maximum score given was 10 points. 
REGISTRATION 
The individuals were told the names of 3 common objects  e. g watch, 
fan, table and then asked to repeat them. One point was awarded for each 
correct answer.  
Maximum  score was 3 points. 
ATTENTION AND CALCULATION 
The individuals were asked to spell "WORLD" backwards - DLROW. 
One point was awarded to each correct answer.  
Maximum score was 5 points. 
  
RECALL 
The individuals were asked to repeat the names of the three objects which 
were learnt earlier. One point was awarded to each correct answer.  
Maximum score was 3 points. 
LANGUAGE 
i. CONFRONTATION: The individuals were shown 2 common objects and 
asked to name them. One point was awarded to each correct answer. 
ii. The individuals were asked to repeat a phrase with no ifs, and or buts of 4 
to 5 words. One point was awarded if repeated correctly. 
iii. COMPREHENSION: The individuals were asked to follow a three staged 
command like “Take this paper in your right hand, fold it in half and put 
it on the floor”. One point was awarded to each stage if done correctly. 
iv. The individuals were asked to read and obey a simple command like 
“close your eyes”. One point was awarded if the act was done correctly. 
v. The individuals were asked to write a sentence of their own choice with 
Subject, Verb, Object). One point was awarded if written correctly. 
 Maximum score for language function  was 8 points 
COPYING: 
CONSTRUCTION : The individuals were asked to copy a design (a pair 
of intersecting pentagons). One point was awarded if  drawn correctly. 
 
Maximum score of 1 point was awarded. 
A total score of 30 points is possible. The score obtained by the 
individual was calculated and recorded. 
 
 
STROOP TEST : 
The test contains 176 boxes (11x16) of 4 names of colours (red, yellow, 
blue, green) randomly coloured and printed.  While testing, the individual first 
reads the words in part 1 and names the colour in the second part. The subject 
is instructed to respond as fast as he can and accurately. The time taken for 
each parts and difference between the two are measured. This test requires 
about 15 minutes to complete.  There was no time limit to complete a subtask. 
An interference measure was calculated by subtracting the average time needed 
to complete the first and second task (Interference = Reading time-naming 
time). Valentin et al., 2005). The errors made during  the test was not 
considered. Although many participants spontaneously corrected themselves 
when they noticed an error (which requires a certain amount of time, indirectly 
corrected for poor accuracy), this was not always the case. Number of errors 
made while reading and naming were  also recorded. 
 COGNITIVE EVOKED POTENTIAL STUDY 
Cognitive Evoked Potential study23 was done for all the individuals in the 
study. 
EQUIPMENT 
The Cognitive Evoked Potential was recorded using a computerised 
recorder.  
FIGURE- 7 
COMPUTERISED RECORDER OF COGNITIVE EVOKED 
POTENTIAL 
 The machine used in this study was RMS EMG EP MARK II(Recorders 
and Medicare Systems Pvt. Ltd., Chandigarh. The machine includes a 
stimulator, recording electrodes, filter, amplifier, signal 90 verage, electrical 
safety.  
 * Stimulator: 
The auditory stimulus in the form of clicks was given to both the ears via 
transducer placed in the head phone. 
* Recording Electrodes: 
Surface silver / silver chloride disc electrodes are used for recording the 
potentials. 
* Filter:  
Filter is a device, which selectively restricts a particular frequency 
domain. The filter band is the frequency range, which is transmitted through the 
filter. The frequency range which is rejected is known as stop band. Filtering is 
necessary for eliminating the noise and optimising the electro physiological 
recording. Filtering also brings out the characteristics of the wave form. 
The low frequency filter removes the low frequency components and 
allows higher frequencies to pass the filter and are called high pass filters. 
Similarly the high frequency filter removes the higher frequencies and allows 
only the low frequency they are also known as low pass filters. 
Filter setting for Cognitive evoked potential recording is as follows 
Low pass filter  30 – 100 Hz 
High pass filter 0.3 – 1 Hz 
* Amplifiers: 
ERPs are small relative to the spontaneous brain activity i.e., they have a 
low signal to noise ratio .Since the biological signals are very small, they need 
to be amplified. Cognitive evoked potentials are usually amplified 10,000 times. 
* Signal  Averager: 
To increase the signal to noise ratio ERP averaging is done. To separate 
the cognitive evoked responses from the background EEG signal, averaging is 
done. This is based on the fact that the evoked potential electrical activity is 
time specific, whereas the random electrical activity is not time specific. 
PREPARATION OF THE INDIVIDUALS 
The individuals were instructed to have a shampoo bath on the day of 
recording and were advised not to use hair spray or oil. They were taken to a 
silent sound proof  room, and made to sit down comfortably in a chair with eyes 
closed.  
Electrode Placement: 
The electrode placement sites were cleaned with spirit and cotton. 
Electrode paste was used to reduce the impedance below 5 kilo ohms. The 
electrodes were placed according to International 10 – 20 system. 
*  Active surface recording  electrode  was placed on Vertex – Cz 
* Two linked reference  electrodes,  one on each mastoid (A1 &A2) with a 
jumper  electrode. 
* Ground electrode was placed over the forehead. 
RECORDING THE COGNITIVE EVOKED POTENTIAL 
The cognitive evoked potential was recorded in a silent room using the 
standard auditory odd ball paradigm23. Random sequences of two 
distinguishable auditory clicks were delivered binaurally. It includes frequent 
stimuli (80%) of 1 KHz frequency and rare stimuli (20%) of 2 KHz frequency. 
The individuals were asked to raise their finger on hearing the rare 
stimuli. The intensity of the stimuli was 60 db above hearing level. The stimuli 
were presented at the frequency of 1 per second, each lasting for 100 milli 
seconds. The responses were filtered with a band pass filter of 0.3 – 30 Hz; the 
responses were amplified 10,000 times and averaged for 40 responses. The 
individuals were asked to fix their eyes on a particular point on the wall during 
recording to avoid electro oculographic artefacts. 
The waves were then computed separately for rare and frequent stimuli. 
The latency of the N100, and P300 waves, and P300 wave amplitude of the rare 
stimuli were noted down.  
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RECORDING OF CEP IN RECORDERS MEDICARE SYSTEMS (RMS 
EMG EP MARK – II MACHINE) 
 
NEUROPHYSIOLOGY LAB, 
DEPARTMENT OF PHYSIOLOGY 
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   Results  
 STATISTICAL ANALYSIS 
The collected data was analysed with SPSS 16.0 version. To describe 
about the data descriptive statistics frequency analysis, percentage analysis were 
used for categorical variables and the mean and S.D were used for continuous 
variables. 
Independent t-test was used to find the significance difference between 
the bivariate samples in Independent groups (stable COPD group & Controls). 
The one way ANOVA with Tukey's Post-Hoc test was used for the multivariate 
analysis. 
 Pearson's Correlation was used to assess the relationship between the 
variables. Chi-Square test was used to find the significance in categorical data.  
In all the above statistical tools, the probability value .05 is considered as 
significant level.Results were expressed as mean+/-standard deviation.  
 
 
 
 
RESULTS 
 This study was to evaluate  cognition in stable COPD patients by 
neuropsychological and neurophysiological methods and to correlate  cognition 
with arterial oxygen saturation. To compare it with the normal controls.  
THE CHARACTERISTICS OF CONTROL AND STABLE COPD 
PATIENTS  
The characteristics of control and stable COPD patients are presented in 
Table 1. 
 A total of 50  stable COPD patients were recruited for the study. All were 
males and they were in the age group of 45-56yrs with a mean of 48 ±10 yrs of 
age and for the control group 49.46 ±7.24. There was no significant difference 
between the two groups with respect to age, height and educational status. They 
all had their education up to primary school. With regard to age,  education, and 
socioeconomic status, the distribution of subjects both in  stable COPD  patients 
and control group was equal. The mean duration of illness  in the COPD 
patients was found to be 8.980 ± 3.13 .Most of the COPD patients were 
labourers 28 number in  stable COPD  patients group and 23 number in the 
control group and they were exposed to dust. They were all smokers with a 
mean smoking pack years of 35.45±10.95 for the COPD patients and it is 
8.23±5.89 for the control group.  
The General and Central Nervous System Examination were found to be 
normal in both control and  stable COPD patients.  
 
TABLE 1 
DEMOGRAPHIC CHARACTERISTICS (MEAN ± SD) OF THE  
STABLE COPD PATIENTS AND CONTROL GROUP 
Variables Control group n= 50 Mean ± SD 
Stable COPD patients 
group n= 50 Mean ± SD 
Age (years) 49.46±7.24 50.43±6.63 
Duration of 
illness 
NIL 8.980±3.13 
Smoking in pack 
years 
8.23±5.89 35.45±10.95 
Height ( meters) 1.60±0.09 1.59±0.07 
Weight( kg) 57.54±11.09 52.90±8.84 
BMI (kg/m2) 22.49±3.99 20.77±3.03 
 
 The comparison of weight  and BMI between the stable COPD patients  
and the control group is given in graphs 1&2. 
 
 
 
GRAPH- 1 
COMPARISON OF (MEAN ± SD) values in WEIGHT BETWEEN THE 
STABLE COPD PATIENTS AND THE CONTROL GROUP 
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 GRAPH-2 
COMPARISON OF (MEAN ± SD) values in BMI BETWEEN THE 
STABLE COPD PATIENTS  AND THE CONTROL GROUP 
 
 The Stable  COPD  patients they fall under the category of normal weight 
(18-22kg/m2) according to new classification for  Asian Indians  BMI is 
20.77±3.03 and for controls is 22.49±3.99 with  p value .017 which is highly 
significant. 
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 The comparison of Occupational status of the stable COPD patients and 
the control group is given in Table-2. 
TABLE 2 
COMPARISON OF OCCUPATIONAL STATUS OF THE CONTROL 
AND  STABLE COPD PATIENTS 
 
STABLE 
COPD group CONTROLS 
OCCUPATION 
Labourers 
28 26 
54.9% 52.0% 
Others 
22 24 
45.1% 48.0% 
 
  
  
  The Distribution of smoking Habit in the stable COPD patients and the 
control group is given in Table-3. 
TABLE-3 
DISTRIBUTION  OF   SMOKING HABITS   IN THE STABLE COPD 
PATIENTS AND THE CONTROL GROUP 
 
STABLE COPD 
patients Group CONTROLS 
Smoking 
Ex 
Smokers 
17 1 
33.3% 2.0% 
Current 
Smokers 
3O 25 
60.8% 50.0% 
Non 
Smokers 
3 24 
5.9% 48.0% 
  
 In the STABLE COPD group, smokers were grouped as ex- smokers, 
current smokers and in the control group- ex-smokers current smokers. 
  
 The Comparison of Smoking pack years between the stable COPD 
patients and control group is presented in Table-4. 
TABLE-4 
COMPARISON OF SMOKING PACK YEARS BETWEEN THE 
STABLE COPD PATIENTS AND CONTROL GROUPS 
 
Stable COPD pts 
group Controls 
SMOKING                 
TOBACCO 
Non smokers 
2 24 
3.9% 48.0% 
Less than 20 pack 
years 
9 16 
19.6% 32.0% 
More than 20 
pack years 
39 10 
76.5% 20.0% 
 
             Smoking is calculated in pack years. In  Stable COPD patients, smokers 
more than 20 pack years were  39(76.5%) and less than 20 pack years is 
10(20%) where as in control it were 10(20%) more than 20 pack years, and less 
than 20 pack years 16(32%). 
 
 
  
 The Classification of mean values of  FEV1 based on the severity of 
COPD ( GOLD GUIDELINES) is given in Table-5. 
TABLE-5 
STAGING OF COPD BASED ON MEAN VALUES OF FEV1%(GOLD 
GUIDELINES) 
STAGING No of Stable COPD pts 
FEV1% 
MEAN±SD 
p value 
STAGE-
I(Mild) 16 87.19±6.274  
STAGE-
II(Moderate) 35 65.69±8.751 .000 
Controls 50 88.02±11.315  
 
 ** Highly Sig. at p < .01 level 
 The mean values of FEV1%  of mild and moderate COPD patients 
were 87.19 ± 6.274 and 65.69 ± 8.751 respectively with a p value of.000 which 
is highly significant when compared to controls which were 88.02±11.315 
 
 
 
PULMONARY FUNCTION TESTS 
The comparison of mean values of FEV1, FVC, FEV1/FVC between the 
stable COPD patients and control groups is shown in Table-6  and graph-3 
TABLE-6 
COMPARISON OF FEV1, FVC, FEV1/FVC BETWEEN STABLE  COPD  
PATIENTS AND CONTROLS 
  
Variables 
Control group 
n= 50 
Mean ± SD 
Stable COPD 
patients 
n= 50 
Mean ± SD 
p value 
FEV1 2.81 ± 0.21 0.96±0.39 0.000 ** 
FVC 3.96 ± 0.68 1.61±0.53 0.000 ** 
FEVI/FVC 0.70  ±.09 0.59±0.11 0.000 ** 
** Highly Sig. at p< .01 level , * Sig. at p < .05 level & # No Sig. 
 
 The mean values of FEVI, FVC and FEV1/ FVC in the  STABLE COPD 
patients were significantly lower (p value of.0001) when compared with the 
control  group.  
 
 
 GRAPH- 3 
COMPARISON OF FEV1, FVC, FEV1/FVC  BETWEEN STABLE  COPD  
PATIENTS AND CONTROLS 
 
NEUROPSYCHOLOGICAL TESTS 
 The Comparison of mean values of MMSE Score between the Stable 
COPD patients and the control group is given in Table - 7 & Graph-4 
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TABLE-7 
COMPARISON OF MEAN VALUES OF MMSE SCORE BETWEEN 
THE  STABLE COPD PATIENTS AND THE CONTROL GROUP 
Variable Control group 
n= 50 Mean±SD 
Stable COPD group 
n= 50 Mean ± SD 
p value 
MMSE 29.58±0.84 24.94±1.94 0.00 ** 
      ** Highly Sig. at p < .01 level , * Sig. at p < .05 level & # No Sig. 
COMPARISON OF MEAN VALUES OF MMSE SCORE BETWEEN 
THE STABLE COPD AND THE CONTROL GROUP 
GRAPH-4 
 
 A  highly significant decrease in the MMSE score with a p value of 0.00 
was observed in the  Stable COPD patients when compared with the control 
group.  
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The comparison of  mean values of Stroop test  between the Stable COPD 
patients  and control group is given in Table-8 and graph-5. 
TABLE-8 
COMPARISON OF  MEAN VALUES OF STROOP TEST  BETWEEN 
THE STABLE COPD PATIENTS AND CONTROL GROUP 
Variable 
Control group 
n= 50 
Mean±SD 
Stable COPD 
patients n=50 
Mean±SD 
p value 
STROOP IN 
SEC 
69.50 ± 30.86 112.75 ± 38.68 0.00 ** 
** Highly Sig. at P < .01 level , * Sig. at P < .05 level & # No Sig 
COMPARISON OF MEAN VALUES  OF STROOP TEST BETWEEN 
STABLE  COPD PATIENTS AND THE CONTROL GROUP 
GRAPH-5 
 
 The mean value of Stroop test score is significantly ( p value of .0001) 
increased when compared to the controls.  
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 COGNITIVE EVOKED POTENTIAL STUDY: The comparison of 
the mean values of  N100 wave latency, P300 wave latency, P300 wave amplitude 
between the control and   Stable COPD patients are given in the  Tables 10-12 
& Graphs-7-9. 
TABLE-9 
COMPARISON OF THE MEAN VALUES OF  N100 WAVE LATENCY 
BETWEEN THE CONTROL AND THE  STABLE COPD PATIENTS 
Variables Controls MEAN ± SD 
Stable COPD patients 
MEAN ± SD p value 
Latency of N100 
in ms 
85±7.86 95.79±20.03 .001 ** 
 
** Highly Sig. at p < .01 level , * Sig. at p < .05 level & # No Sig. 
COMPARISON OF THE MEAN VALUES OF N100 WAVE LATENCY 
(ms) IN THE  STABLE COPD PATIENTS AND CONTROL GROUP 
GRAPH-6 
 
 
 
 
 A  highly significant increase in the N100 wave latency at Cz is observed 
in the  stable COPD  patients when compared to control group with a p value of 
.001. 
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TABLE-10 
COMPARISON OF THE MEAN VALUES OF  P300 WAVE LATENCY 
(ms) BETWEEN THE CONTROL AND THE  STABLE COPD 
PATIENTS 
Variables Controls MEAN ± SD 
stable COPD 
patients 
MEAN ± SD 
p value 
Latency of P300 
(ms) 
301.02 ± 9.38 335.22 ± 21.41 .0001 ** 
** Highly Sig. at p < .01 level , * Sig. at p < .05 level & # No Sig. 
COMPARISON OF THE MEAN VALUES OF  P300 WAVE 
LATENCY(ms) BETWEEN THE CONTROL AND THE  STABLE COPD 
PATIENTS 
GRAPH-7 
 
 A  highly significant increase in the P300 wave latency at Cz  in the Stable  
COPD  patients group with a mean value of 335.22 ± 21.41 on comparing with 
the control group with a p value of .0001.  
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TABLE-11 
COMPARISON OF THE MEAN VALUES OF  P300 WAVE AMPLITUDE  
BETWEEN THE CONTROL AND THE STABLE  COPD  PATIENTS 
Variables Controls MEAN ± SD 
Stable COPD 
patients 
MEAN ± SD 
p value 
p300 amplitude 
in µv 
9.88 ±13.02 5.10±1.45 0.010 ** 
 
 
 The mean value of P300 wave amplitude at Cz  in the Stable  COPD  
patients is decreased significantly ( p value of 0.010) when compared with the 
control group. 
COMPARISON OF THE MEAN VALUES OF  P300 WAVE AMPLITUDE  
BETWEEN THE CONTROL AND THE STABLE  COPD  PATIENTS 
GRAPH-8 
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ARTERIAL OXYGEN SATURATION  
Comparison of mean values of arterial oxygen saturation between   Stable 
COPD  patients and control group is given in Table-12 & Graph-9 
TABLE-12 
COMPARISON OF MEAN VALUES OF ARTERIAL OXYGEN 
SATURATION  VALUES BETWEEN STABLE COPD PATIENTS  AND 
CONTROL GROUP 
Variable 
Control group 
n= 50 
Mean ± SD 
Stable COPD  pts 
group n= 50 
Mean ± SD 
p value 
SpO2 99.60±0.70 96.00±2.35 
0.00 ** 
 
 
** Highly Sig. at p < .01 level , * Sig. at p < .05 level & # No Sig. 
COMPARISON OF MEAN VALUES OF ARTERIAL OXYGEN 
SATURATION  VALUES BETWEEN  STABLE COPD PATIENTS AND 
CONTROL GROUP 
GRAPH-9 
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 In the Stable COPD patients, the arterial oxygen saturation is 
significantly (p-value of .0001) lower when compared with the controls. 
ARTERIAL OXYGEN SATURATION AND ARTERIAL OXYGEN 
TENSION  
 The  mean values of Arterial oxygen saturation & Partial pressure of 
oxygen in  Stable COPD  patients  is given in Table-13 
TABLE-13 
MEAN VALUES OF ARTERIAL OXYGEN SATURATION & PARTIAL  
PRESSURE  OF OXYGEN IN  STABLE COPD  PATIENTS 
Variable Total No of Stable 
COPD patients 
MEAN ± SD 
SaO2 50 95.135±2.58 
PaO2 50 77.671±15.13 
 
CORRELATION BETWEEN ARTERIAL OXYGEN TENSION AND 
MMSE SCORE, STROOP TEST SCORE, N100 LATENCY, P300 
LATENCY AND P300  AMPLITUDE 
 The correlation between Arterial oxygen tension and MMSE, Stroop test, 
N100 latency, P300 latency and P300 amplitude is given in Table 14 - 17 
 
 
 TABLE-14 
CORRELATION BETWEEN ARTERIAL OXYGEN TENSION AND 
MMSE  IN STABLE COPD PATIENTS : 
  
CO
RR
EL
ATI
ON 
BE
TW
EEN  ARTERIAL OXYGEN TENSION AND STROOP TEST IN  
STABLE COPD PATIENTS : 
TABLE-15 
 Correlation coefficient 
and p value 
Interpretation 
Correlation between  
arterial oxygen tension & 
Stroop test in Stable 
COPD patients 
r = .067 
p = .640 
Weak positive 
correlation 
Not significant 
 
 
Correlation 
coefficient and 
pvalue 
Interpretation 
Correlation between  
arterial oxygen 
tension  & MMSE 
score in  Stable 
COPD patients 
r = -0.124 
p = 0.388 
Weak negative 
correlation 
Not significant 
TABLE-16 
CORRELATION BETWEEN  ARTERIAL OXYGEN TENSION AND 
P300 LATENCY IN( m sec) IN  STABLE COPD PATIENTS : 
 Correlation coefficient 
and p value 
Interpretation 
Correlation between  
arterial oxygen 
tension  & P300 
latency in ms in 
Stable COPD 
patients 
r = .200 
p = .159 
Weak positive 
correlation 
Not significant 
 
TABLE-17 
CORRELATION BETWEEN  ARTERIAL OXYGEN TENSION AND 
P300 AMPLITUDE IN( µV) IN COPD PATIENTS : 
 Correlation 
coefficient and p 
value 
Interpretation 
Correlation between  
arterial oxygen tension  
& P300 Amplitude in µV  
in  Stable COPD patients 
r =.270 
p = .55 
Positive correlation 
Not significant 
 
  
  
  
 Discussion  
 DISCUSSION 
 All stable COPD patients included in this study fulfilled GOLD 
CRITERIA for assessing the severity of COPD. They were all symptomatic 
with H/o difficulty in breathing, productive cough, and fatigue. 
Stable patients included in this study were on regular treatment for 6 or 
more months with no history of exacerbations. 
CHARACTERISTICS OF STUDY SUBJECTS : 
The mean age of stable COPD patients included in the study was 48 ± 10 
yrs of age ranging from 38 years to 58 years. In a study by Hulya Ortapamuk 
et al103, the study group were within the range of 45 - 65 years, Orth et al 87, 
included the age group more than 55 years, Jing Li et al studied age group more 
than 65 years and in a study by Prem Parkash Gupta et al104,  the subjects 
were in the age group more than 40 years.  
Due to the high prevalence of COPD among males, the present study 
included only male individuals. 
The mean  value of duration of illness in COPD patients was 8.980 ± 3.13 
yrs. The mean value of smoking in pack years in COPD patients was 
35.45±10.95, which was significantly more when compared to the controls. 
Occupational exposure to dust was found to increase the severity of disease 
process which in turn influences the development of cognitive impairment in 
COPD patients. Above results were consistent with the study done by Prem 
Parkash Gupta et al104. 
Among the COPD patients, 76.5 %  had > 20 smoking pack years, 19.6 %  
had < 20 smoking pack years and 3.9 % were non smokers. This shows that 
smoking is an important risk factor for COPD. Smoking has a direct neurotoxic 
effect. It increases carbon monoxide level causing cerebral hypoxia which plays 
an important role in the pathogenesis of COPD and cognitive dysfunction as 
suggested by Antonella De Carolis et al in 2011 and he found out that 
processing speed and verbal memory were affected in his study group due to 
smoking. 
The mean value of body mass index was 20.77 kg/m2  in COPD patients 
which was significantly lower (22.49 kg/m2 ) when compared to controls. In a 
study by  Gupta et al 105, malnutrition was present in 83% of COPD patients. It 
is  due to the end result of an imbalance between energy intake and 
consumption by the body. Impairment of leptin regulation and inadequate 
intake due to difficulty in breathing leads to decreased BMI. 106 
Staging of COPD patients was done  based on GOLD CRITERIA for 
COPD severity using FEV1% values. The number of patients in stage I (mild) 
were 16 with the mean value of FEV1% as 87.19 ± 6.27 and 35 patients were in 
stage II (moderate) with a mean  value of FEV1% as 65.69 ± 8.75. Thus the 
present study included mild and moderate stable COPD patients. Similarly, in a 
study done by Jing Li et al and Gupta et al, COPD patients belonging to mild 
and moderate stages were included unlike in studies done by Fix et al, Grant et 
al and Ohrui et al, who  included only severe group .  
The present study was carried out to assess the cognitive status and to 
record the early changes that occur in the neuronal cells induced by hypoxia. 
Hence COPD patients who were exposed to hypoxic episodes during their daily 
activities, sleep and during exertion were included in this study. Hypoxic 
episodes were also seen during acute exacerbation of the illness, which is very 
common and not reported often in COPD patients with cognitive impairment 
due to loss of self assessment of illness.  
NEUROPSYCHOLOGICAL TESTS:  Many studies have assessed 
cognition by a battery of neuropsychological tests. Cognition domains are 
multiple and there are a number of specific tests to assess each domain. 
Neuropsychological testing requires time and a trained psychiatrist to perform  
and to  interpret the findings.  
MMSE SCORE :  
In this study the mean values of MMSE score in COPD patients was 
24.94±1.94 which was significantly lower than the controls. Among the 
cognition domains, verbal memory and motor speed were significantly impaired 
in COPD patients. These observations are similar to the study done by  Prem 
Parkash Gupta et al 104, In a study by Grant14 et al and Prigatano99 et al in 
1987, poor MMSE scores in COPD patients was related to moderate and severe 
hypoxemia. 
Reduced MMSE scores observed in COPD patients in the present study, 
suggests cognitive dysfunction in them. 
Cognitive impairment was observed in COPD patients in many studies 
like Fix AJ98 et al, Grant I et al 14, Stuss D T et al 84, Fioravanti M et al111. 
Recall was the important domain to be affected in COPD  patients along with 
decline of verbal memory  and this holds true in the present study where most of 
the COPD subjects were not able to recall and copy a design. Allen and co-
workers107-110 had confirmed that low performance on the MMSE and its 
intersected pentagon part are significantly linked to worse performance in the 
ability to learn and retain inhaler techniques and it is consistent with our study. 
STROOP TEST SCORES: 
 
In this study, the subjects showed poor performance in naming than 
reading and the interference score was significantly affected  with a mean value 
of  112.75±38.68 sec. In a study by Fix A J et al in 1982, the 
neuropsychological tests which included stroop colour and word test scores 
were significantly related to partial pressure of arterial oxygen (PaO2), and to 
degree of pulmonary impairment. The cognitive deficits were real, but small. 
Igor Grant, MD et al14 in their study in 1999, found that higher cognitive 
functions (abstracting ability, complex perceptual-motor integration) most 
severely affected but half the percentage of patients showed decrements in 
motor speed, strength, and coordination. Kozora et al112 in 1999, showed that 
COPD patients  performed significantly worse than  the controls on verbal 
fluency tasks. Incalzi R A et  al81 in his study, observed that 48.5% of COPD 
patients  had a specific pattern of cognitive deterioration which was 
characterized by a dramatic impairment in verbal memory tasks,  and diffuse 
worsening of the other function. Above findings are consistent with our study. 
Abnormal  stroop test scores observed in the COPD patients, indicates impaired 
cognitive flexibility. 
COGNITIVE EVOKED POTENTIAL STUDY 
In the present study, the COPD patients had significant prolongation of  
N100  and P300 wave latencies and decreased P300 wave amplitude, when 
compared to the control group.  
  In our study, there was significant prolongation of N100 latency  with a 
mean value of 95.79±20.03  when compared to controls. The N100 wave is the 
largest component and it is considered to reflect initial sensory processing and 
early selective attention capacities during stimulus processing causing arousal 
and attention (Strik et al, 1992).  
             The mean value of P300 latency in COPD patients was 335.22 ± 21.41 
which was significantly increased when compared to controls. Similar results 
were observed in studies done by  A.R AL Tahan, et al, Kirkil G et al 115  and   
Gupta PP et al.  
          P300 test can be considered as a potential objective marker of cognitive 
impairment.  The P300 is   used as a surrogate marker of information 
processing, attention and intellect memory. During acute exacerbation of 
COPD Patients were reported to have impaired attention, information 
processing and  memory. 
 The mean value of P300 amplitude in COPD patients was 5.10 ± 1.45. 
This was significantly lower when compared to controls. Similarly decrease in 
p300 amplitude was observed in studies by A.R AL Tahan et al., and Gupta PP 
et al., 
 P300  amplitude depends on the selective attention of the individual. It is 
greater with attentive individual, and with better motivation and task priority. 
 The significantly prolonged N100 wave latency, P300 latency and decreased 
P300 amplitude in the COPD group implies impaired attention. 
ARTERIAL OXYGEN SATURATION AND ARTERIAL OXYGEN 
TENSION  
In our study, the men arterial oxygen saturation in COPD patients was 
96.00 ± 2.35 % when compared to controls. The mean arterial oxygen tension 
(PaO2) in COPD patients was found to be 77.67 ± 15.13 mm Hg. However it 
was in the normal range. The PaO2 usually remains near normal until the FEV1 
is decreased to nearly 50% of predicted and even much lower FEV1 values can 
be associated with a normal PaO232. Oxygen desaturation may occur during day 
to day activities leading to demyelination of cerebral cortex in COPD patients. 
Reduced SpO2  is due to low V/Q ratio  leading to physiologic shunt  and high 
V/Q ratio  leading to increased physiologic dead space in  COPD subjects and it 
is a risk factor  for COPD exacerbation (Faganello M M et al114, 2010). Orth 
et al87 in 2006, observed  a significant association between SpO2 and 
COPD severity. Rabe KF et al113 (2007),  observed that  as alveolar hypoxia 
progresses to hypoxemia, the severity of COPD increases. 
National Emphysema Treatment trial by Martinez FJ et al in 2006119 and 
UPLIFT study done by Tashkin DP et al in 2008, revealed that COPD patients 
were hypoxic and they required Oxygen therapy. This proves that hypoxemia is 
the major factor  causing cognitive impairment. Liesker JJ et al86,  observed 
that even non-hypoxemic patients with COPD showed significant impairment in 
cognitive performance and this goes hand in hand with the present study.  
CORRELATION OF VARIABLES 
There was no significant correlation between arterial oxygen tension and 
MMSE, Stroop test, and P300 latency. However there was a positive correlation 
between arterial oxygen tension and P300 amplitude but it was not statistically 
significant. The reasons for weak correlation could be attributed to minimum 
sample size covered in the study and only few percentage of COPD patients fall 
beyond the mean ± 3' SD value range of normal subjects with respect to all 
variables assessed in the study.  
Kim V Benidict JO et al (2008) stated that," hypoxemia leads to poor 
cognitive function, poor quality of life, and finally  increased risk of COPD  
exacerbation and death". In a study by Fix et al, decreased PaO2  correlated 
with attention, processing speed, and motor function. Stuss et al observed 
memory changes in relation to PaO2. Allen  SC, Jain M, Ragab S, et al in 
2003108, showed that in COPD patients, SpO2 was significantly decreased. 
SpO2 and PaO2 were significantly correlated with pulmonary involvement. 
They suggested that intact cognition is essential for the use of inhaler by the 
COPD patients.  
 Finally, early cessation of smoking  in COPD patients will help to reduce 
the comorbidities like cognitive impairment. Cognitive impairment is seen in 
61% of moderately hypoxemic and 27% of mildly hypoxemic patients in the 
present study. Treatments should be designed to improve brain oxygenation in 
order to prevent the progression of cognitive dysfunction in COPD patients. 
Supplemental oxygen therapy (Kropp et al  in 1973114,Heaton et al in 
1983) demonstrated slight improvement in motor speed and strength, exercise 
training. It has reduced post exercise sympathetic hyper arousal, improved 
neurotransmitter regulation and oxygen carrying capacity of the blood. This 
improved verbal fluency, processing and thus frontal lobe executive functions 
(Dustman et al in 1984)118. Rehabilitation (Emery et al., 1998, 2001, 2003117), 
and Lung volume reduction surgery  improved psychomotor skills and verbal 
naming with improvement in quality of life (Kozora et al., 2005112). 
Thus it is clear that  intact cognition is essential for the COPD patients so 
that the treatment can be planned to prevent hypoxic episodes which is the 
major cause of cognitive impairment and to delay the progression of illness by 
Pulmonary  Rehabilitation. 
  
 
 
 
 
 
 
 
 
  
  
 Conclusion  
 CONCLUSION 
The following conclusions have been derived from the present study, 
It is proved that there is definite cognitive impairment in Stable  COPD 
patients when compared with the controls.  The Stable COPD patients were in 
normal, mild and moderate stages of hypoxia as indicated by Partial Pressure of 
oxygen.  Inspite of having near normal oxygen levels, there is cognitive 
impairment as assessed by MMSE, Stroop colour word test and  the Cognitive 
evoked potential study. 
In Stable COPD Patients, the Central nervous system involvement is 
clearly  proved by the non-invasive cognitive assessment  tests. In future, these 
tests  may be recommended in all  stable COPD patients as a routine 
investigation 
1)  to detect early impairment of  cognition, 
2)  to plan our management to improve cognition and 
3) to delay the progression of illness by Pulmonary Rehabilitation 
which will improve the quality of life in COPD patients. 
 
  
  
 Summary  
SUMMARY 
 
This cross sectional comparative study was done in the Neurophysiology 
Laboratory, Department of Physiology, Govt. Stanley Medical College, 
Chennai-1 to assess cognition by  MMSE, Stroop test and Cognitive  evoked 
potential  study and to correlate with arterial oxygen  tension  in Stable COPD 
patients.  
The study included 50 Stable COPD patients and 50 controls.  
MMSE score was significantly lower in Stable COPD patients. Stroop 
test score was significantly altered in Stable COPD patients when compared 
with the controls. The Latency of N100 and P300 wave of cognitive evoked 
potential was prolonged and P300 amplitude was decreased.   
Arterial oxygen saturation and tension was found to be significantly 
decreased in patients. Though there was a positive correlation between arterial 
oxygen tension and P300 amplitude in COPD patients, it was not statistically 
significant. 
The above results show that hypoxia can be attributed to impairment in 
cognition. MMSE can be used as a screening tool, and Stroop test to assess 
cognitive flexibility. CEP study can be used to identify early cognitive 
impairment. Further studies are required to  assess cognition after cognitive 
training and pulmonary rehabilitation to know whether cognitive impairment is 
reversible or it stops its progression which would be helpful in  the prompt 
management of the condition.        
The above results were discussed and compared with other published 
studies. 
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 Annexure  
 PROFORMA 
 
Proforma  for the study subject :                                                  Date: 
1.  S. no :                                                                                                                                                                      
2.  I.D (given by investigator):                       Address &Contact No. 
3.  Name : 
4.  Age : 
5.  Gender  :                          Religion: 
6.  Pulmonology  Dept.No. /Master Health checkup no.: 
7.  Occupation : Not working/Housewife/labourer- what type of work:                     duration: 
/Professional/others(specify): 
8.  Family History of COPD,TB: Parents  / Siblings 
9. Educational Qualification   : uneducated/school /College/ Professional : 
10.  Per Capita Income: 
                       Number of family members : 
                       Net family income: 
 
11.  Duration of illness : 
12.  Social Habits : 
 Past/present/
Newer 
Beedi/Cigarette/Brand/
quantity/Pack years 
Duration 
1. Smoking           /day 
 
 
  
2. Alcohol    
3. Tobacco    
4. Any other 
substance abuse 
   
 
13. Past history: 
 14. Treatment history: Increased need for  drugs: oral  IM/IV  Inhaler   Nebulizer Number 
of hospitalisations:   :Duration of stay:   ICU/Mechanical ventilatory support 
15. Associated Co morbidities: 
Clinical Details: 
16.  Symptoms :                                                  Duration:                                                     
        *Cough: dry or productive 
        *Difficulty in breathing : 
        *Fever: 
        * Chest pain: 
        *Loss of weight: 
        * Loss of appetite: 
          Fatigue 
          Sleep disturbance:  
          Palpitation 
          Activity limitation 
        *any other  relevant complaints: 
17. On Examination : 
        *  Height : 
        * Weight :       
        * Built : 
        * Nourishment  
         * B M I : 
  Respiratory rate :                 Pulse:                        Blood Pressure : 
          Clinical Examination of Respiratory System: 
 
 
18. Investigations :    Urine Examination: 
Blood Investigations: RBC count:         WBC count:             Hb%:                    PCV: 
Blood Glucose:                                    Serum Electrolytes: 
Pulse Oximetry:             Blood arterial gas analysis: pH 
X-ray chest PA  view                                 PO2       
ECG in all leads                                         PCO2     
Spirometry: FVC:                                      HCO3   
FEV1: 
FEV1% 
FEV1/FVC%: 
PEFR   :    
Clinical Diagnosis : 
19.            MMSE Scale:  
20.           Stroop test: 
                                           
21.   Event Evoked Potential Response: 
  Variables   
Latency   
Amplitude   
 
 
 
  
  
 
 
 
 
 
 
 
 
STANDARDIZED MINI-MENTAL  STATE EXAMINATION(SMMSE) 
 QUESTION TIME ALLOWED SCORE 
a.     What year is this? 10 seconds /
1 
 b.     Which season is this? 10 seconds /
1 
 c.     What month is this? 10 seconds /
1 
 d.     What is today’s date? 10 seconds /
1 
 e.     What day of the week is this? 10 seconds /
1 
a.     What country are we in? 10 seconds /
1 
 b.     What province are we in? 10 seconds /
1 
 c.     What city/town are we in? 10 seconds /
1 
 d.     IN HOME – What is the street address of this 
house? 
IN FACILITY – What is the name of this 
building? 
10 seconds /
1 
 e.     IN HOME – What room are we in?  IN FACILITY – What floor are we on? 10 seconds /
1 
SAY: I am going to name three objects. When I am finished, I want you to repeat them. Remember what they 
are because I am going to ask you to name them again in a few minutes. Say the following words slowly at 
1‐second intervals ‐ ball/ car/ man 
20 seconds /
3 
Spell the word WORLD. Now spell it backwards. 30 seconds /
5 
Now what were the three objects I asked you to remember? 10 seconds /
3 
SHOW wristwatch. ASK: What is this called? 10 seconds /
1 
SHOW pencil. ASK: What is this called? 10 seconds /
1 
SAY: I would like you to repeat this phrase after me:  No ifs, ands or buts. 10 seconds /
1 
SAY: Read the words on the page and then do what it says. Then hand the person the sheet with CLOSE 
YOUR EYES on it. If the subject reads and does not close their eyes, repeat up to three times. Score only if 
subject closes eyes 
10 seconds /
1 
HAND the person a pencil and paper. SAY:  Write any complete sentence on that piece of paper. 
(Note: The sentence must make sense. Ignore spelling errors) 
30 seconds /
1 
PLACE design, eraser and pencil in front of the person. SAY: Copy this design please. 
 
Allow multiple tries. Wait until person is finished and hands it back. Score only for correctly copied 
diagram with a 4‐sided figure between two 5‐sided figures. 
1 minute /
1 
ASK the person if he is right or left‐handed. Take a piece of paper and hold it up in front of 
the person. SAY: Take this paper in your right/left hand (whichever is non‐ dominant), fold 
the paper in half once with both hands and put the paper down on the floor . Score 1 point 
for each instruction executed correctly. 
Takes paper correctly in hand 
Folds it in half 
Puts it on the floor 
30 seconds  
 
 
 
 
 
/
1 
/
1 
/ TOTAL TEST SCORE  /30 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Master chart  
CONTROLS 
S.NO. AGE SEX OCCUPATION EDUCAT smoking duration BMI FEV1 FVC FEV1% FEV1/FVC SpO2% MMSE STROOP N1in ms  P300 ms p300-N2µv 
                        oximetry   in sec latency latency amplitude 
1 47 M LABOURER SCHOOL NIL   24.539 2.9 3.45 104 0.84 100 30 60 98.8 281.3 8.58 
2 40 M LABOURER SCHOOL NIL   25.631 2.98 4 94 0.74 98 30 60 87.9 299 5.81 
3 45 M LABOURER SCHOOL present OCCATIONAL 21.368 2.71 3.25 102 0.83 100 30 90 83.5 286.6 7.88 
4 40 M LAB TECH COLLEGE NIL   23.951 2.67 3.89 82 0.68 100 30 60 90.2 309.4 5.04 
5 40 M LABOURER SCHOOL present OCCATIONAL 22.277 3 3.29 111 0.91 100 28 60 90.4 309.4 10.71 
6 46 M LABOURER SCHOOL present 15/D-1YR 23.335 2.23 4.12 68 0.54 98 30 60 100.9 287.5 6.55 
7 40 M COOLY SCHOOL present OCCATIONAL 22.277 2.68 4.89 68 0.54 98 30 60 75 313.5 4.45 
8 46 M COMPUTER OPER SCHOOL present OCCATIONAL 25.391 3.07 4.26 91 0.72 100 30 60 71.9 287.5 9.23 
9 41 M ELECTRICIAN COLLEGE present OCCATIONAL 23.781 2.89 4.12 90 0.7 100 30 90 86.5 295.8 10.3 
10 55 M OFFICE ASST SCHOOL present OCCATIONAL 23.781 2.79 4.27 79 0.65 100 29 60 76 310.4 5.48 
11 55 M CARPENTER SCHOOL present 10/D-20yrs 26.635 2.57 4.89 65 0.52 100 30 60 94.6 302.1 10.31 
12 50 M PLUMBER SCHOOL present OCCATIONAL 24.221 2.67 3.98 81 0.67 98 29 60 76 310.4 5.48 
13 56 M CLERK SCHOOL 4YRS   25.631 2.54 3.67 83 0.69 100 30 60 91.5 281 10.58 
14 39 M DRIVER SCHOOL present OCCATIONAL 2.422 2.78 4.12 81 0.67 100 30 60 87.5 318.8 12.99 
15 31 M CLERK SCHOOL NIL   23.438 2.65 3.9 81 0.67 100 30 150 99.8 284.4 10.73 
16 51 M ELECTRICIAN SCHOOL present OCCATIONAL 16.437 2.87 3.79 95 0.75 98 26 15 78.1 308.3 9.55 
17 54 M OFFICE ASST SCHOOL 3YRS   26.898 2.67 4.1 79 0.65 99 29 90 62.5 296.9 10.68 
18 58 M LABOURER SCHOOL present 5/D-25yrs 23.733 2.96 4 95 0.75 99 30 90 89.6 288.5 10.8 
19 59 M LABOURER SCHOOL NIL   22.862 2.87 3.45 102 0.83 100 30 15 81.3 307.3 6.55 
20 45 M CONTRACTOR SCHOOL NIL   25.631 3.04 4 96 0.76 100 29 60 88.5 317.7 9.67 
21 47 M LABOURER SCHOOL NIL   22.583 2.67 3.25 101 0.82 99 28 60 89.6 302.1 8.05 
22 54 M LABOURER SCHOOL NIL   22.862 2.56 3.89 79 0.65 100 27 120 89.6 300 8.98 
23 57 M LABOURER SCHOOL NIL   23.438 2.83 3.29 105 0.86 99 30 120 78.1 310 6.54 
24 57 M LABOURER SCHOOL NIL   22.862 2.94 4.12 90 0.71 99 30 70 86.5 295.8 10.55 
25 57 M LABOURER SCHOOL NIL   23.011 2.91 4.23 88 0.68 100 29 60 85.5 299 6.9 
26 58 M ELECTRICIAN SCHOOL NIL   23.875 2.98 4.26 83 0.69 99 30 60 89.4 294 7.89 
27 44 M LABOURER SCHOOL NIL   26.563 3.11 4.86 76 0.63 99 30 60 76 312.4 5.81 
28 60 M LABOURER SCHOOL NIL   24.974 2.45 4.89 65 0.5 99 30 90 77.7 298.9 11.8 
29 54 M LABOURER SCHOOL NIL   23.875 2.98 4.89 84 0.6 98 29 60 87.5 298 10.89 
30 50 M LABOURER SCHOOL NIL   23.624 2.9 3.98 92 0.72 100 30 60 86.7 298.9 3.98 
31 40 M LABOURER SCHOOL NIL   26.835 2.89 3.67 98 0.78 100 30 60 83.3 293.6 5.43 
32 56 M LABOURER SCHOOL NIL   20.313 2.31 4.12 70 0.56 100 29 60 99.8 312.9 3.26 
33 55 M OFFICE ASST SCHOOL present 2/D-25yrs 21.484 2.78 3.9 90 0.71 100 29 60 78.9 311.8 8.13 
34 49 M OFFICE ASST SCHOOL NIL   20.313 2.31 3.79 74 0.6 100 30 60 83.9 298.9 8.34 
35 47 M OFFICE ASST SCHOOL NIL   18.424 2.91 4.1 89 0.7 100 30 60 79.9 304 9.87 
36 47 M PEON SCHOOL present 5/D-30yrs 18.424 2.82 4 89 0.7 100 30 60 87.6 309 8.98 
37 47 M OFFICE ASST SCHOOL present OCCATIONAL 17.993 2.86 3.45 101 0.82 100 29 60 91.5 300.7 5.65 
38 42 M PEON SCHOOL present 10/DAY-30yrs 20.984 2.78 4 89 0.69 100 30 150 78.8 289.9 98.7 
39 54 M OFFICE ASST SCHOOL present OCCATIONAL 20.761 2.45 3.25 95 0.75 100 30 120 76.4 287 8.98 
40 40 M OFFICE ASST SCHOOL present OCCATIONAL 22.598 2.96 3.89 96 0.76 100 30 120 89.6 299.9 5.4 
41 38 M CAMERAMAN COLLEGE present OCCATIONAL 21.774 2.95 3.29 108 0.89 100 30 120 89.7 300 7.98 
42 50 M OFFICE ASST SCHOOL present 4/D-20yrs 20.322 2.91 4.12 90 0.7 100 30 60 78.9 300.9 8.56 
43 51 M LABOURER SCHOOL present OCCATIONAL 23.951 2.95 4.89 84 0.6 100 30 15sec 89.8 301.9 8.9 
44 53 M LAB ASST SCHOOL NIL   27.414 2.99 4.26 99 0.8 100 30 60 92.6 299 6.98 
45 41 M SUPERVISER SCHOOL NIL   25.1 3 4.86 85 0.61 100 30 120 74.9 307 4.31 
46 56 M LABOURER SCHOOL present OCCATIONAL 16.135 3 0.6 77 0.64 100 29 60 89.6 299.9 5.4 
47 60 M LABOURER SCHOOL present 10/d-40yrs 16.135 2.98 4.89 74 0.6 100 30 30sec 81.3 309 8.89 
48 58 M LABOURER SCHOOL present 10/d-40yrs 23.922 3 3.98 96 0.75 100 30 60 89.8 300 9.67 
49 55 M LABOURER SCHOOL present 5/D-30yrs 23.922 2.78 3.67 96 0.75 100 30 30SEC 76.9 309.8 10.45 
50 58 M LABOURER SCHOOL present 10/D-10yrs 23.43 3 4.12 91 0.72 100 30 30SEC 79.8 310.8 7.58 
  
 COPD PATIENTS 
S.
No AGEyrs SEX OCCUPATION EDUCATION duration SMOKING BMI   SPIROMETRY     oximetry MMSE STROOP N1in ms 
 P300 in 
ms 
p300-
N2µv ABG 
      NATURE primary illness-yrs pack yrs   
FEV1 
P FEV1 FVC FEV1/FVC SO2 score in sec latency  latency amplitude  Po2 SO2 
1 45 M FISHERMEN SCHOOL 5 12 25.299 76 1.02 1.63 0.62 98 28 150 106.6 345 4.25 66.1 94 
2 65 M Rtd govt s SCHOOL 8 23 17.567 80 1.12 1.68 0.66 95 25 150 89.6 342.7 5.43 51.1 95 
3 50 M LABOURER SCHOOL 6 45 20.395 81 1.33 1.98 0.67 95 23 150 100 356.9 5.81 83.5 93 
4 50 M ELECTRICIAN SCHOOL 8 33 21.403 72 1.12 1.92 0.58 95 24 120 96.9 324.8 5.31 84.4 96 
5 45 M ELECTRICIAN SCHOOL 10 12 20.957 85 1.41 2.02 0.69 96 27 90 99.8 324 4.85 98.2 95.5 
6 55 M LABOURER SCHOOL 7 25 29.297 61 0.84 1.75 0.48 96 21 90 98.9 341.9 7.98 42.1 94 
7 55 M LABOURER SCHOOL 4 35 18.262 48 0.44 1.15 0.39 95 26 90 97.9 302.1 3.31 89.2 96 
8 55 M LABOURER SCHOOL 8 35 18.832 76 1.02 1.6 0.63 97 26 120 89.8 365.6 7.89 87 94 
9 55 M LABOURER SCHOOL 11 35 19.052 95 0.5 0.65 0.75 94 26 120 85.4 330.2 5.98 90 93 
10 48 M LABOURER SCHOOL 15 12 23.438 97 0.51 0.65 0.78 95 24 200 97 345.7 3.09 86 94 
11 44 M SELLER SCHOOL 10 30 23.373 61 0.72 1.45 0.49 93 25 200 100.5 329 7.98 89 94 
12 48 M LABOURER SCHOOL 13 12 18.195 81 1.01 1.5 0.67 94 24 200 117.2 359.8 5.74 91.8 84.3 
13 42 M ELECTRICIAN SCHOOL 10 34 21.644 81 1.2 1.78 0.67 86 24 90 109.8 328.4 5.87 72.8 94 
14 63 M LABOURER SCHOOL 8 23 17.578 85 1.45 2.02 0.71 95 24 90 96.9 382 5.31 92 90 
15 52 M LABOURER SCHOOL 6 12 23.438 83 1.38 2 0.69 91 25 90 193.8 352.2 3.38 98.8 93 
16 63 M LABOURER SCHOOL 7 45 18.73 83 1.4 2.01 0.69 94 27 120 139.6 354.8 4.05 56.8 92 
17 48 M AUTO DRIVER SCHOOL 15 35 20.812 70 1.12 1.98 0.56 93 29 100 99.5 358.3 3.28 43.7 98.6 
18 50 M OFFICE ASST SCHOOL 12 35 20.546 48 0.44 1.15 0.39 99 21 90 144.8 342.8 3.83 80.6 95 
19 52 M WATCHMAN SCHOOL 13 25 24.221 95 2.05 2.71 0.75 98 30 90 110.4 331.4 3.9 56.3 96 
20 66 M LABOURER SCHOOL 12 29 19.031 96 1.09 1.41 0.77 97 26 90 111.7 304.2 3.52 88.7 97 
21 53 M LOADMAN SCHOOL 12 25 21.484 70 1.25 2.16 0.57 99 24 160 82.3 308.3 5.66 67.2 97 
22 62 M SHOP  SCHOOL 10 30 21.224 61 0.53 1.08 0.49 98 26 90 80.9 319.7 3.95 90 95 
23 60 M COOLY SCHOOL 8 35 23.03 77 1.77 2.79 0.63 96 23 90 113 322.9 3.64 91.8 96 
24 54 M LABOURER SCHOOL 9 40 20.812 60 1.05 2.18 0.48 96 26 240 87.9 324.8 7.89 66.6 95 
25 58 M LABOURER SCHOOL 7 25 21.63 62 0.73 1.46 0.5 95 21 90 87.9 351.7 3.78 67.4 98 
26 58 M LABOURER SCHOOL 6 20 23.011 65 1.38 2.59 0.53 98 26 200 89.6 305.2 5.9 91.8 96 
27 45 M LABOURER SCHOOL 6 15 24.974 61 1.33 2.6 0.51 98 25 90 82.3 342.2 6.08 69.2 96 
28 50 M GOVT.PEON SCHOOL 5 15 14.872 71 0.75 1.28 0.58 96 25 120 84.4 321.8 4.35 62.3 94 
29 55 M LABOURER SCHOOL 7 13 24.238 60 0.69 1.39 0.49 94 23 120 89.6 302.1 5.87 62.5 95 
30 54 M LABOURER SCHOOL 8 10 17.578 68 0.64 1.13 0.56 95 25 90 78.2 311.5 3.33 84.5 99 
31 47 M LABOURER SCHOOL 9 35 23.438 75 0.85 1.38 0.61 100 25 120 98.5 384.4 7.02 89.1 90 
32 55 M LORRY SHED SCHOOL 11 13 19.531 94 1.17 1.59 0.75 99 30 60 81.3 382.9 6.87 82 98 
33 50 M WATCHMAN SCHOOL 15 40 30.458 74 0.85 1.4 0.6 98 25 90 87.5 306.3 5.87 82.8 96 
34 52 M LORRY SHED SCHOOL 17 45 18.365 60 1.05 2.18 0.48 98 26 90 89.6 319.8 3.68 92.6 96 
35 42 M TAILOR SCHOOL 13 35 22.039 83 1.52 2.2 0.69 97 25 90 99.5 305.2 4.31 90.5 96 
36 60 M LABOURER SCHOOL 11 10 24.167 67 0.31 0.56 0.55 96 26 60 88.8 340.6 4.86 87.7 99 
37 55 M DECORATION SCHOOL 7 10 17.8 76 1.5 2.4 0.62 99 24 60 71.9 342.8 3.99 62.5 94 
38 48 M COOLY SCHOOL 8 20 22.641 48 0.4 1.1 0.36 95 24 90 76 324.7 5.11 44.6 98 
39 37 M LORRY DRIVER SCHOOL 9 25 20.202 48 0.44 1.15 0.39 98 26 120 94 354.7 3.57 94.9 99 
40 60 M SECURITY SCHOOL 13 35 18.491 67 0.94 1.68 0.55 99 24 90 98.6 345.1 6.98 66.6 97 
41 45 M COOLY SCHOOL 6 25 20.546 68 1.02 1.77 0.57 98 24 100 89.7 301 7.98 78.1 95 
42 42 M SILVER POLISH SCHOOL 7 10 19.592 56 0.47 1.02 0.46 96 24 100 76.1 340.7 4.86 82 94 
43 55 M SECURITY SCHOOL 6 15 20.269 71 0.68 1.16 0.58 97 24 100 89 327.7 5.89 82.5 96 
44 48 M LABOURER SCHOOL 10 15 16.135 71 0.67 1.15 0.58 96 26 120 84 346 4.08 81 96 
45 53 M PAINTER SCHOOL 12 10 17.8 91 1.45 1.95 0.74 94 24 120 90 345 4.86 62.5 92 
46 48 M COOLY SCHOOL 6 12 19.382 75 0.7 1.18 0.59 96 25 130 76 335.7 4.77 60.5 94.9 
47 55 M LABOURER SCHOOL 6 24 17.8 77 0.7 1.15 0.6 95 24 90 98.8 321.7 5.87 82.5 95.9 
48 60 M COOLY SCHOOL 5 26 18.975 60 0.62 1.29 0.48 96 21 90 78.1 312.9 6.89 100 97.9 
49 62 M SECURITY SCHOOL 8 25 17.8 85 1.11 1.56 0.71 97 24 90 79.2 361 3.11 66.6 93.7 
50 45 M LABOURER SCHOOL 9 30 18.975 68 0.61 1.15 0.53 96 25 90 87 345 4.66 85.2 96.6 
